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ABSTRACT
The increasing prevalence of drug-resistant pathogens is an urgent problem that requires novel
methods of bacterial control. Plant extracts inhibit bacterial pathogens and could contain
antibacterial compounds with novel mechanisms of action. Yerba mate, a common South
American beverage made from Ilex paraguariensis, has antibiotic activity against a broad range
of bacterial pathogens. In this work, an attempt was first made to characterize the antibacterial
source of an aqueous yerba mate extract by generating a series of extract fractions, collecting
GC-MS and antibacterial activity profiles, and then ranking the hundreds of compounds by their
presence in fractions with high antibacterial activity. Quinic acid, quercetin, and 5-hydroxy
pipecolic acid were highly ranked, suggesting an association between the antibacterial activity of
yerba mate against methicillin-resistant Staphylococcus aureus (MRSA). Next, metabolites that
accumulated in the supernatants of Salmonella Typhimurium and Lactobacillus casei cultures
were surveyed for decreases in phenolic compounds that might signify metabolism of bioactive
yerba mate components. No decreases in phenolic compounds were observed. The hypothesis
that phenolic compounds might chelate iron as a mechanism of antibacterial activity was also
tested; exogenous iron sulfate stimulated the partial recovery of S. Typhimurium to the inhibitory
effect of yerba mate in a milk system. Finally, an assessment of potential antibacterial
mechanisms of action was undertaken by surveying the metabolites produced by Salmonella
Typhimurium in the presence of yerba mate extract and conducting assays to assess cell
membrane integrity and catalase activity. No effect on the cell membrane was observed while
catalase activity was reduced in the presence of yerba mate extract. Metabolomics revealed
significant differences in central carbon metabolism, the cell wall precursor UDP-Nacetylglucosamine, the regulatory metabolites alpha-ketoglutarate and acetylphosphate, the

iv
energy metabolite NAD+, and a match to yohimbine, which has known antibacterial activity.
Future work can move closer to understanding the antibacterial value of yerba mate extract and
its constituents by testing specific mechanistic hypotheses based on metabolic alterations, further
examining 5-hydroxy pipecolic acid and yohimbine for antibacterial activity and mechanism, and
annotating currently unknown compounds that could have antibacterial activity or be additional
key metabolites pointing to specific mechanisms of action.
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CHAPTER I
INTRODUCTION
Emergence of antibiotics
The germ theory of disease proposed by Louis Pasteur and Robert Koch changed popular
approaches to medicine in the late 1800s and encouraged “chemotherapy” treatments with
antiseptic chemicals. However, internal bacterial infections remained a major problem,
particularly as fatal secondary infections of influenza victims in the 1918 pandemic (reviewed by
Brundage & Shanks, 2008). A solution came serendipitously to Alexander Fleming, who
observed that a contaminating mold (Penicillium notatum) prevented the growth of bacteria on
an unattended agar plate (Fleming, 1929). Despite a delay of more than a decade in gaining
recognition and mass production, the mold-produced penicillin stimulated the golden age of
antibiotics in the 1950s, during which many novel compounds with new mechanisms of action
were discovered and put to use in combating human and animal bacterial disease. Unfortunately,
the beginnings of a new threat presented itself as strains of penicillin-resistant staphylococci
were noted, and were associated with “adaptation” (Abraham et al., 1941) to penicillin. Since
then, selection pressure for bacterial pathogens with resistance mechanisms have led to rising
populations of pathogens with resistance to many common antibiotics; there are thus fewer and
fewer treatment options remaining for infections of these bacteria (reviewed by Levy &
Marshall, 2004). The urgency of this problem is highlighted by a study published less than a
month ago that reported on a strain of E. coli with resistance to colistin, a “last resort”
antibacterial, that was found in the U.S. for the first time (McGann et al., 2016). The everincreasing presence of multi-drug resistant bacteria has pushed the search for new compounds
and new mechanisms of action, but the search strategies of the 1950s, which focused on bacterial
and fungal-derived compounds and their synthetic derivatives (reviewed by Lewis, 2013), seem
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to be unfruitful in finding new antibacterial drugs. This has promoted a recent trend of searching
other domains of life, including plants, for novel antibacterial compounds.
Antibacterial resistance overview
Antibacterial resistance exists through alterations in antibacterial-targeted cell structures, the
modification or metabolism of the antibacterial, reduced permeability of the cell, and active
efflux pumps that remove antibacterial compounds from the cell (Figure 1). Common
antibacterial classes have distinct mechanisms of action that result in distinct resistance
mechanisms. Beta-lactams act on the cell wall by binding penicillin-binding proteins, so
resistance mechanisms include mutant penicillin binding proteins and beta-lactamase enzymes
that degrade beta-lactam antibacterials. Macrolides, tetracyclines, aminoglycosides, and
oxazolidinones all act on the ribosome (reviewed by Walsh et al., 2003) but in different binding
locations, resulting in resistance mechanisms based on binding site mutations, modification of
the antibacterial, and efflux by efflux pumps (reviewed by Wilson, 2014). Fluoroquinolones
target DNA gyrase, so DNA gyrase mutants, altered cell permeability, and efflux pumps are
mechanisms of fluoroquinolone resistance. Membrane permeability changes and efflux pumps
can specifically exclude or remove certain chemical classes, or they can act non-specifically to
prevent multiple classes of chemicals from entering the cells or to actively export them
(reviewed by Kumar & Schweizer, 2005).
This dissertation focuses on two globally relevant bacterial pathogens: methicillinresistant Staphylococcus aureus (MRSA), which has been implicated in thousands of deaths
annually in the U.S. (CDC, 2013), and Salmonella enterica serovar Typhimurium, which was
implicated in 30 deaths and thousands of infections in the U.S. in 2014 (CDC, 2015).
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The most obvious approach to combat growing antibacterial resistance is to find new
antibacterial compounds, but traditional search strategies of screening for inhibitory activity tend
to rediscover the same compounds and directed high-throughput screens have had limited
success; screening strategies have been limited by proper target selection and limited chemical
diversity (reviewed by Silver, 2011). Natural products, though, could be a viable source of
diverse chemical structures that are capable of inhibiting pathogenic bacteria by novel
mechanisms, as this dissertation will explore.
There are alternative, cooperative strategies to discover novel compounds that are also
being considered. With the increasingly limited effectiveness of existing antibacterial
compounds, social and cultural strategies to carefully regulate antibacterial use have been
proposed. These strategies include better tracking of the spread of resistance to guide control
methods, halting the prophylactic use of sub-therapeutic concentrations of antibacterials in
domestic animals and plants, isolating hospitalized individuals with multi-drug resistant (MDR)
infections, and working with healthcare providers to differentiate viral from bacterial infections
(reviewed by Levy & Marshall, 2004). Since the development of resistance will remain an issue
even with novel antibacterials that have novel mechanisms of action, social strategies will likely
be necessary to maintain effective antibacterial treatments.
Additional strategies to combat antibacterial resistance by interfering with virulence
factors (i.e. toxins, quorum sensing) are also an active area of investigation and show promise for
inhibiting disease-causing traits of bacterial pathogens without selecting for resistance in the
population (reviewed by Bhardwaj, Vinothkumar, & Rajpara, 2013; Hauser, Mecsas, & Moir,
2016). The monoclonal antibody raxibacumab was approved by the FDA in 2012 for binding
anthrax toxin in anthrax infections and three other monoclonal antibody inhibitors are currently
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undergoing clinical trials (shigamab, bexlotoxumab, MEDI4893) (reviewed by Hauser et al.,
2016). Phage therapy and microbiome modulation are also potential strategies to fight bacterial
pathogens that may redirect selective pressures so that alternating treatment strategies can be
applied (reviewed by Hauser et al., 2016).
Plants as sources of novel antibacterial compounds
Although alternatives to traditional antibacterial drugs are in development, they are not at a stage
where they can be applied as regular treatment options for major MDR pathogens, so the
continued search for novel compounds in natural products with diverse structures and novel
mechanisms of action is still a valuable route of exploration. An extensive review of the
antimicrobial use of plants by humans has suggested that phytochemicals in particular will be
important in the discovery of novel therapeutics (Cowan, 1999). More recent studies have
validated the potential for specific phytochemicals to effectively inhibit pathogenic bacteria with
known antimicrobial resistance both alone and in synergy with other compounds; in one example
a compound blocked the non-specific resistance mechanism of efflux pumps and another
compound exerted a toxic effect (Tegos, Stermitz, Lomovskaya, & Lewis, 2002). Many whole
plant extracts have also been observed to have antibacterial activity against bacterial pathogens,
but only a subset of these studies have actually delved into the mechanistic questions that must
be addressed in order to understand the circumstances under which a botanical can effectively
inhibit bacterial pathogens.
This work focused on an initial characterization of the antibacterial activity of an aqueous
extract of yerba mate. Yerba mate is a beverage prepared from the heat-processed leaves of Ilex
paraguarienses and has a long history of human use in South American culture. It has been
found to have antibacterial activity against Staphylococcus aureus, methicillin-resistant
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Staphylococcus aureus (MRSA), Salmonella, Listeria, and pathogenic Escherichia coli (Burris,
Davidson, Stewart, & Harte, 2011; Burris, Higginbotham, & Stewart, 2015; El-Sonbaty &
Araby, 2014; Girolometto, Avancini, Carvalho, & Wiest, 2009; Gonzalez-gil et al., 2014; Martin
et al., 2013; Rempe et al., 2015). As an extract that is “generally recognized as safe” (GRAS) by
the U.S. Food and Drug Administration (FDA) for human consumption (electronic Code of
Federal Regulations, subpart A, 182.20), it could be a useful antibacterial additive to foods and
might contain bioactive components with novel antibacterial mechanisms. Yerba mate is known
to contain a diverse array of phytochemicals, including polyphenolics, xanthine alkaloids (the
stimulants caffeine, theobromine, and theophylline), and saponins (Heck & De Mejia, 2007).
Phytochemical classes with known antibacterial activity include phenolics, terpenoids, alkaloids,
lectins, polypeptides, and polyacetylenes (Cowan, 1999). Phenolic compounds are abundant in
yerba mate and include the antibacterial compounds quercetin, kaempferol, caffeoylquinic acids,
and feruloylquinic acids (Heck & De Mejia, 2007). Although these compounds should
contribute to the antibacterial activity of yerba mate, no previous attempts have been made to
determine whether one of these phenolics or another compound was the major contributor to
antibacterial activity. Furthermore, while mechanisms of quercetin and kaempferol alone have
been assayed, no previous attempts have been made to survey the mechanisms of action of the
whole extract. This dissertation reviews the known mechanisms of action of plant phenolic
compounds, reports an initial effort to identify the constituents of yerba mate contributing to
antibacterial activity against MRSA, and investigates the major mechanisms of action enacted by
the whole extract against S. Typhimurium.
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Scope of dissertation
This dissertation is organized into 6 chapters. This introduction provides a short history of
antibacterial development, mechanisms of antibacterial resistance and strategies to overcome
antibacterial resistance, and an overview of plants as a source of antibacterial compounds with a
focus on yerba mate. Chapter 2 discusses the known mechanisms of action of phenolic
compounds and the role of systems biology methods in discovering novel mechanisms of action.
Chapters 3-5 encompass the breadth of the research; Chapters 3 is a published peer-reviewed
article, Chapter 4 is unpublished, and Chapter 5 will be submitted for peer-reviewed publication.
Chapter 3 investigated the yerba mate compounds that contributed to antibacterial activity
against methicillin-resistant Staphylococcus aureus based on the computational comparison of
yerba mate fractions with differing antibacterial activities. Chapter 4 evaluated the accumulated
metabolites of Salmonella Typhimurium and Lactobacillus casei grown in the presence of yerba
mate in a milk system. Chapter 5 assessed the metabolic pathways of Salmonella Typhimurium
at time points selected to glean information into the mechanisms of action of yerba mate extract.
Finally, conclusions and future research directions are discussed in Chapter 6.
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Appendix
Figures

Figure 1. Bacterial mechanisms of resistance to antimicrobials. Inability of antimicrobial to
cross cell barrier (decreased penetration), active membrane pump to shuttle out toxic compounds
from within the cell (efflux pump), enzymatic degradation of antimicrobials (modification or
inactivation of enzymes), and modification of the target site (prevents binding) (adapted from
Abreu et al., 2012).
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CHAPTER II
SYSTEMS BIOLOGY APPROACHES TO UNRAVELING
ANTIBACTERIAL MECHANISMS OF PLANT PHENOLIC COMPOUNDS
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A version of this chapter will be submitted to the Journal of Applied Microbiology for peerreviewed publication by Caroline S. Rempe, Kellie P. Burris, Scott C. Lenaghan, and C. Neal
Stewart, Jr.:

CS Rempe, SC Lenaghan, KP Burris, and CN Stewart, Jr. contributed to the conception, writing,
and revising of this review article.
Summary
Drug resistance of bacterial pathogens is a growing problem that can be addressed through the
discovery of compounds with novel mechanisms of antibacterial activity. Plants offer a plethora
of compounds that have demonstrated broad antibacterial activity. While plant phenolic
compounds may provide novel mechanisms of action, only known mechanisms of action have
been evaluated. With systems biology approaches, antibacterial mechanisms can be assessed
without the bias of target-directed bioassays to enable the discovery of novel mechanism(s) of
action against drug resistant microorganisms.
Key words: phenolic, antibacterial, mechanisms of action, systems biology
Introduction
Each group of multi-drug resistant bacteria has been directly linked to thousands of deaths
annually across the globe, with resistant Shigella species and Mycobacterium tuberculosis each
causing more than one million deaths annually (WHO, 2014). In the United States (U.S.), drug
resistant bacteria are the primary cause of more than 23,000 deaths and 2 million serious
infections each year, of which resistant Clostridium difficile, Enterobacteriaceae species, and
Neisseria gonorrhoeae are considered “urgent threats” (CDC, 2013). These numbers will
continue to rise as multi-drug resistant bacteria become more prevalent; the recent
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documentation of colistin-resistant Escherichia coli in the U.S. suggests that even “last resort”
antibiotics with major side effects are likely to lose their effectiveness (McGann et al., 2016).
Phenolic compounds found in plants can combat multi-drug resistant bacteria (reviewed by
Abreu, McBain, & Simões, 2012), but their mechanisms of action must be thoroughly
characterized before they can be rationally used as antibacterial treatments. Several common
mechanisms of action have been verified to contribute to the antibacterial activity of phenolic
compounds, but very few attempts have been made to seek novel mechanisms of action.
The general structural categories of plant-derived phenolics, as categorized by Cowan
(1999), include simple phenolics, phenolic acids, quinones, flavonoids/flavones/flavonols,
coumarins, and tannins. Although phenolics are classified as compounds with a hydroxylated
aromatic ring, Cowan categorized flavones as “phenolic structures containing one carbonyl
group” (Cowan, 1999), which prompted the inclusion of flavones in this work. A useful review
of phytochemical classes and their general antibacterial modes of action has already been
compiled (Borges, Saavedra, & Simões, 2015), as has as a detailed review of flavonoid
mechanisms of action, including cytoplasmic membrane damage, topoisomerase inhibition,
NADH-cytochrome c reductase inhibition, and ATP synthase inhibition (Cushnie & Lamb,
2011). More recent flavonoid reviews have focused on mechanisms of action involving cell
membranes (Tsuchiya, 2015; Verstraeten, Fraga, & Oteiza, 2015). The mechanisms of action of
phenolic compounds were additionally reviewed with an emphasis on structural features
correlated to specific mechanisms (Gyawali & Ibrahim, 2014).
Most methods to determine antibacterial mechanisms are target-directed assays that
directly test single proteins or other cellular targets in vitro. These target-directed methods are
required to fully understand mechanisms of action, but they have no chance of identifying novel
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targets since activity assays only assess whether or not the pre-selected target was inhibited. An
expansion to undirected systems biology approaches that survey all targets within the detection
range for a given technology will allow for the identification of novel mechanisms of action that
can combat multi-drug resistant bacterial pathogens. Target-directed assays are very informative
since established bioassay protocols against a single target can definitively assign binding and
inhibitory activity of compounds with enzymes known to be essential to cell survival. However,
target-directed assays also limit the scope of mechanisms that can be identified, which is
undesirable when existing antibacterial mechanisms of action threaten to become obsolete with
the rise of resistant bacteria. This is where undirected approaches like systems biology have
value, in the broad, unbiased survey of possible mechanisms that can be used to formulate new
hypotheses for novel target-directed assays.
In this review, we aim to assess the current state of mechanistic investigations of plant
phenolic antibacterial compounds and survey systems biology approaches that have successfully
contributed to determining antibacterial mechanisms.
Membrane disruption by phenolic compounds
Membrane disruption, in both Gram-positive and Gram-negative bacteria, contributes to the
antibacterial activity of most plant phenolics that have been mechanistically assessed (Table 1).
Many of the membrane integrity analyses cited in Table 1 combined several common, simple
methods to monitor the influx of hydrophobic dyes or antibiotics, the efflux of intracellular
constituents, and microscopic observation. While these membrane permeability analyses
provided valuable information about membrane disruption, they gave little, if any, direction to
the specific major mechanisms of action of a compound. Furthermore, they generally left an
open question as to whether the compound altered membrane stability by interfering with
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intracellular processes or by direct interaction with membrane components. Other more unique
assays have also been conducted, for example, in the quantification of cell surface
hydrophobicity the tendency of a hydrophilic water drop to spread or bead when in contact with
a bacterial lawn was measured (Borges, Ferreira, Saavedra, & Simões, 2013). This assay more
specifically characterized the effect of gallic and ferulic acids, which were observed to increase
surface hydrophilicity of Gram-negative bacteria and hydrophobicity of Gram-positive bacteria
(Borges et al., 2013). Nevertheless, this measure of surface hydrophobicity could also be
attributed to either direct interaction with the membrane or an interaction with intracellular
components that impact cell wall chemistry.
Once a membrane effect is known to exist, specific binding assays or model membrane
insertion assays (T. Wu, He, et al., 2013) can confidently test direct interactions between specific
components. Model membranes have already been used to test the direct interaction of
epicatechin gallate and epigallocatechin gallate with membranes (Hashimoto, Kumazawa, Nanjo,
Hara, & Nakayama, 1999; Kumazawa et al. 2004). However, the extensive diversity in bacterial
membrane composition (Sohlenkamp & Geiger, 2016) would likely require specific assays with
each organism of interest. Another unique assay that may be useful in assessing direct membrane
binding is the addition of exogenous magnesium to a basic membrane integrity assay. This
assessment revealed a dependence on magnesium akin to an ethylenediaminetetraacetic acid
(EDTA) control for the membrane-disrupting activity of gallic acid (Nohynek et al., 2006). Since
magnesium ions are known to stabilize Gram-negative bacterial membranes, this simple assay
might easily test direct membrane interactions involving magnesium, though other integral cell
functions involving magnesium should also be considered.
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A particularly in-depth study was conducted for epigallocatechin gallate’s mechanism of
action against methicillin-resistant Staphylococcus aureus (MRSA) and its contribution to
renewed beta-lactam susceptibility. The study assessed purified cell wall components,
phosphorus content, the effects of exogenous peptidoglycan on activity, adherence to glass,
penicillin binding protein abundance, Triton-X-100 autolysis, bacteriolytic enzymes, free
lipoteichoic acid, and lysostaphin’s pentaglycine cleavage activity. Each of these methods
focused on addressing a particular hypothesis of epigallocatechin gallate’s mechanism of action,
which is an ideal, albeit time-consuming, approach for a mechanistic assessment. Nevertheless,
the specific mechanism of action remained unknown despite the new knowledge of
epigallocatechin gallate’s observed cell adherence, accumulated autolysins, increased
lipoteichoic acid release, lack of effect on penicillin binding proteins, and reduced effect on
Triton-X autolysis and lysostaphin lysis (Stapleton, Shah, Ehlert, Hara, & Taylor, 2007). Another
method that has given mechanistic insight, but not a specific mechanism of action, was the use of
high resolution gas chromatography (HRGC) lipid profiling to identify specific lipids altered by
the presence of eugenol, carvacrol, or thymol in both Gram-negative and Gram-positive bacteria
(Di Pasqua et al., 2007). All three tested phenolics were observed to increase major fatty acids
(palmitic, oleic, cis-10 heptadecenoic acids) in Gram-negative bacteria while Gram-positive S.
aureus lipid profiles changed across several fatty acids. S. aureus treatment with thymol, though,
resulted in a clear increase in saturated fatty acids and decrease in unsaturated fatty acids, which
could be due to a desaturase response to cell leakage (Di Pasqua et al., 2007). While this type of
untargeted assessment requires interpretation, it gives a greater depth of information than most of
the basic membrane disruption assays. When iterations of logically planned assays are
performed, as in the epigallocatechin example discussed before the HRGC study, a good depth of
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information is also obtained. However, conducting iterations of assays is time and labor intensive
while HRGC can gather information on many potential targets simultaneously. Although no
liquid chromatography-mass spectrometry (LC-MS) lipidomics experiment to deduce the
mechanisms of action of a phenolic was encountered in the literature, a basic LC-MS experiment
can measure an even larger range of metabolites than HRGC and more confidently identify them;
this technology can profile the relative abundance of thousands of lipids simultaneously and is
easily automated (Wenk, 2005). More untargeted approaches capable of profiling thousands of
compounds in a single experiment will be useful in the rapid generation of mechanistic
hypotheses that can subsequently be tested with a relevant subset of targeted assays.
Non-membrane mechanisms of action
Assessments for non-membrane mechanisms of action can also be categorized into targetdirected assays for known mechanisms of action and undirected experiments that take a systemswide approach to exploring mechanisms of action. Among the plant phenolics tested in Table 1,
targeted assays have discovered DNA gyrase inhibitory activity for 10 phenolic compounds
(Ohemeng, Schwender, Fu, & Barrett, 1993; T. Wu, Zang, He, Pan, & Xu, 2013), type III
secretion inhibition for 9 compounds (Tsou et al., 2016), inhibition of helicase activity for 5
phenolic compounds (Xu et al., 2001), multi-drug efflux pump inhibitors for 3 compounds (Bag
& Chattopadhyay, 2014; Fiamegos et al., 2011; E. C. J. Smith et al., 2007), dehydratase
inhibition for 3 compounds (Zhang et al., 2008), protein kinase inhibition for 2 compounds
(Shakya et al., 2011), and single phenolic compounds among which one inhibited urease activity
(Moon et al., 2013), one bound iron (Chung, Lu, & Chou, 1998), one inhibited succinate
dehydrogenase and malate dehydrogenase (Yao et al., 2012), one intercalated into DNA (Lou et
al., 2012), one induced DNA fragmentation, an ROS response, and suppressed FtsZ expression
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(Hwang & Lim, 2015), and one bound to the FtsZ protein and inhibited FtsZ assembly (Rai,
Singh, Roy, & Panda, 2008). Many of these results clearly come from a single study picking a
mechanism of action and screening several phenolic compounds for activity. This approach
generates valuable information and more such screens are needed to assess phenolic antibacterial
mechanisms. Nevertheless, the major mechanism(s) of a compound could easily be overlooked
with a screening approach if multiple mechanisms exist. This problem seems likely when
looking at one of the most-studied phenolics, quercetin, and its diverse list of mechanisms (cell
membrane disruption, DNA intercalation, DNA gyrase inhibition, type III secretion inactivation,
dehydratase inhibition (HpFabZ), and protein kinase inhibition; Table 1).
A general methodological approach to these targeted assessments was to verify
antibacterial activity, purify the target enzyme, and characterize its phenolic-bound and unbound
structures using spectrophotometric techniques. As an example, after gathering antibacterial
activity data and purifying the FtsZ enzyme, curcumin was observed to inhibit the FtsZ
protofilament assembly by monitoring assembly kinetics with light scattering, to bind to purified
FtsZ based on an increase in bound-curcumin fluorescence at 495 nm, and was noted to alter the
secondary structure of FtsZ based on a circular dichroism analysis (Rai et al., 2008). In some
studies, however, only inhibitory activity was determined and structural binding characteristics
were not assessed (Bag & Chattopadhyay, 2014; Ohemeng et al., 1993; E. C. J. Smith et al.,
2007). The most specific interaction details were found by the 2 studies that obtained crystal
structures of quercetin or apigenin bound to the enzymes they inhibited (Shakya et al., 2011;
Zhang et al., 2008). One of these studies moved to the next step in mechanistic understanding by
introducing a single amino acid mutation to the enzyme in order to verify the importance of a
key binding interaction (Zhang et al., 2008). Unfortunately, the conserved tyrosine that was
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mutated did not alter binding, so the specific, necessary interaction points between quercetin or
apigenen and FabZ still need to be validated (Zhang et al., 2008). There were also 2 studies in
which detailed structure mechanisms were determined with molecular docking, but not further
validated through single amino acid mutation or crystal structures (Fiamegos et al., 2011; Plaper
et al., 2003). Detailed structural characterizations of phenolic binding mechanisms are a valuable
contribution to the field that can facilitate successful computational prioritizations of potentially
active compounds and predictions of compound activities to guide both natural product testing
and rational antibacterial design.
Only one study in Table 1 that is not membrane-specific can be called untargeted: the
proteomics assessment of thymol antibacterial activity against Salmonella Thompson (Di
Pasqua, Mamone, Ferranti, Ercolini, & Mauriello, 2010). This study found altered abundances of
citric acid cycle enzymes, ATP synthesis enzymes, stress-related chaperone proteins, cell
envelope proteins, and an absence of the antioxidant protein thioredoxin 1 in treated cells.
Although a specific mechanism of action was not identified here, valuable information was
produced that verified the cell membrane disruption observed in other thymol-treated Gramnegative bacteria and added several additional possible protein targets. Additional assays to test
different portions of the impacted pathways, thioredoxin, and relevant regulatory proteins are
still needed, of course, but it is now clear that membrane disruption alone was not the sole
mechanism of action of thymol against S. Thompson and that intracellular proteins, including
thioredoxin, may be important targets (Di Pasqua et al., 2010).
Key functional characteristics
Mechanisms characterized to the level of atomic interaction points are rare in the examples of
Table 1, but give the most specific mechanistic information. Crystal structures of quercetin and
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apigenin bound to FabZ showed that quercetin and apigenen, which differ only in 2 hydroxyl
groups, similarly bind between amino acid groups to block substrates from passing through a
tunnel to reach the active site (Zhang et al., 2008). Hydrophobic interactions likely sandwich the
phenolic ring between a tyrosine and proline in one binding site and between a phenylalanine
and an isoleucine in a second binding site. In the crystal structure of quercetin-bound resistance
kinases, hydrogen bonds between hydroxyl groups and nearby amino acids appeared to be the
primary interactions (Shakya et al., 2011). Based on several flavonoids tested, the absence of a
particular carbonyl group was necessary for binding and the hydroxyl position was important
(Shakya et al., 2011). A molecular docking study of quercetin and DNA gyrase proposed that
quercetin has one mechanism by which it binds DNA, stabilizes the DNA-gyrase complex, and
induces DNA cleavage in addition to a second mechanism by which it inhibits DNA supercoiling
by competitively binding to the ATP binding site of the DNA gyrase B subunit (Plaper et al.,
2003). Another molecular docking study surveyed the localization of caffeoylquinic acids to an
efflux pump and determined that caffeoyquinic acids tended to bind in a position that blocked the
efflux pump (Fiamegos et al., 2011).
Similar trends in functional groups that contribute to bioactivity are seen in many
structure activity relationship studies. Electron distribution, as impacted by the number and
location of hydroxyl groups and double bonds, has been the major factor associated with
antibacterial activity of flavonoids (reviewed by Gyawali & Ibrahim, 2014; Shapiro &
Guggenheim, 1998; Wu, Zang, et al., 2013; Wu, He, et al., 2013). Electron localization and other
structural features also impact molecular hydrophobicity, which impacts the types of membrane
interactions that are possible.
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Other studies have found hydroxyl counts and positions to be important for bioactivity
extending beyond flavonoids and into the broader category of phenolics. A quantitative structure
activity relationship (QSAR) analysis with more than 100 phenolics and related compounds used
MIC values against the oral bacteria Porphyomonas gingivalis, Selenomonas artemidis, and
Streptococcus sobrinus and found that a hydroxyl group attached to an aromatic ring was
required for low MICs (Shapiro & Guggenheim, 1998). Exceptions to the general trend of key
hydroxyl placement have been observed through isomers that had different antibacterial
activities, suggesting that chirality is also an important factor (Friedman, Henika, & Mandrell,
2002; reviewed by Gyawali & Ibrahim, 2014). Interestingly, the number of hydroxyl groups has
also been correlated with antioxidant activity (reviewed by Balasundram, Sundram, & Samman,
2006; Rice-Evans, Miller, & Paganga, 1996). However, any relationship between antioxidant
activity and antibacterial activity is not fully understood.
Synergistic antibacterial activity
If specific mechanisms of action are known, phenolic compounds can be rationally combined
with other antibacterial compounds to synergistically combat multi-drug resistant bacteria.
Synergistic effects have already been observed for many phenolic compounds when combined
with antibiotics currently in use (reviewed by Aiyegoro & Okoh, 2009; Amin, Khurram,
Khattak, & Khan, 2015; Hemaiswarya & Doble, 2010; essential oil components reviewed by
Langeveld, Veldhuizen, & Burt, 2014; Lim et al., 2016; Oh & Jeon, 2015). Many synergistic
effects have been attributed to membrane-disrupting compounds, including phenolics, that allow
intracellular toxins faster/easier access to their targets (Amin et al., 2015; Hemaiswarya & Doble,
2010; Oh & Jeon, 2015). Additionally, strains that use efflux pumps to remove toxins can be
attacked by blocking the efflux pumps with one compound and applying an intracellular toxin as
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a second compound for synergistic killing (Oh & Jeon, 2015; reviewed by Prasch & Bucar,
2015; Tegos & Stermitz, 2002). The down-regulation of efflux pump proteins has also been
observed (Oh & Jeon, 2015). Synergistic effects between other modes of action may also exist
and could improve the functionality of existing antibacterial compounds, especially in combating
drug resistance mechanisms.
Systems biology methods
Phenolic compounds from natural sources have been assessed for antibacterial mechanisms
related to membranes and specific protein and/or pathway targets (Table 1; Figure 2). However,
most of these assays are limited to target-directed tests of known antibacterial mechanisms and
do not facilitate the discovery of novel mechanisms of action or multiple mechanisms of action.
An undirected systems biology approach could reveal the major known and/or unknown
mechanism(s) of action (Vincent, Ehmann, Mills, Perros, & Barrett, 2016). In particular, -omics
approaches could reveal unknown mechanisms quickly, with less effort than other systems
biology approaches.
Non-omics systems biology approaches include affinity chromatography, which requires
immobilizing the antibacterial compound in a column, eluting it with any bound proteins, and
then characterizing the bound protein (reviewed Wong, Cheng, He, & Chen, 2008); phage
display of translated peptides, which requires several rounds of “biopanning” to remove phagedisplayed peptides that were not bound by the tested antibacterial compound (reviewed Wong et
al., 2008); and the high-throughput but still time intensive methods of screening for novel targets
followed by screening for inhibitors of targets (reviewed by Harvey, Edrada-Ebel, & Quinn,
2015; Miesel, Greene, & Black, 2003; Payne, Gwynn, Holmes, & Pompliano, 2007). Also
included are time-intensive chemical-chemical interaction approaches that screen the effects of a
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compound of unknown mechanism in combination with each compound of a diverse set of
antibiotics with known mechanisms (Farha & Brown, 2010). A recent review discussed another
major method, the time-consuming construction and screening of genetic mutants for
antibacterial resistance (Farha & Brown, 2016). This method has had success, but also has the
potential to simply reveal mechanisms of resistance that are distinct from mechanisms of
antibacterial action.
Metabolomics is capable of using µl volumes of extracted samples to gain information on
potentially thousands of metabolites that define antibacterial mechanisms in 30 min per sample
for some system platforms (Lu et al., 2010). The major limitations of -omics approaches are the
ranges of detection for different technologies and the availability of annotated information for a
given organism. In the metabolomics example, high resolution LC-MS systems can give a good
representation of major bacterial metabolic pathways, but lipids, high molecular-weight
compounds, and volatile compounds generally require separate runs on different instrument
platforms (reviewed by Aretz & Meierhofer, 2016; Dettmer, Aronov, & Hammock, 2007). On
the annotation aspect, bacterial pathogens have long been a focal point of bacterial research, so
they are relatively well studied and have readily accessible, consistently annotated data in a
recent database dedicated to pathogens (Wattam et al., 2014), though annotated genomes and
metabolomes in general are still far from comprehensive (Aretz & Meierhofer, 2016; Médigue &
Moszer, 2007). Thus, -omics analyses should be a viable option for determining antibacterial
mechanisms of uncharacterized compounds. Metabolomics has already proven useful for
determining mechanisms of action that impact specific metabolic functions. The mechanisms of
action of a thymidine kinase inhibitor (AZ1), a 1-deoxy D-xylulose 5-phosphate (DXR) pathway
inhibitor (fosmidomycin), and a lipid A synthesis inhibitor (CHIR-090) were readily identified
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with E. coli metabolomics data by data analysts blinded to the antibiotics used (Vincent et al.,
2016). However, in the analysis of other compounds, the metabolomics data showed non-specific
upregulation of many metabolites for a peptidoglycan cross-linking inhibitor, a DNA ligase
inhibitor, and an enoyl-acyl carrier protein inhibitor. Furthermore, no discernible metabolic
differences were observed between a control and an antibiotic treatment that uncoupled the
proton gradient of the electron transport chain. Measurement limitations in observing
peptidoglycan molecules (too large) and mono-, di-, and tri-phosphates (differing ionizabilities)
were possible reasons for the lack of relevant information from the peptidoglycan inhibitor and
oxidative phosphorylation inhibitor (Vincent et al., 2016). Belenky et al. (2015) were also able to
differentiate antibacterial compound treatments based on the affected E. coli metabolome after
60 and 90 min of treatment, but not after 30 min. It was not specified whether the known cellular
targets of ampicillin, kanamycin, and norfloxacin could be determined from their respective
metabolomes, but the ROS hypothesis of cell death was supported based on similarly high levels
of a metabolic marker for DNA/RNA oxidation across all antibiotic treatments (Belenky, Ye,
Porter, Cohen, et al., 2015). Another metabolomic study successfully used the exometabolome of
S. aureus to determine the previously unknown antibacterial mechanism of action of
triphenylbismuthdichloride (TPBC). By comparing the exometabolome of TPBC-treated S.
aureus to the exometabolomes of kanamycin, ciprofloxacin, trimethoprim, and fluoropyruvate it
was observed that only TPBC and fluoropyruvate continuously accumulated pyruvate. Thus, the
pyruvate dehydrogenase inhibition activity of TPBC was hypothesized and then verified by an
enzyme activity assay with cell lysate (Birkenstock et al., 2012). Another study used a similar
comparison methodology to hypothesize the mechanism of the non-phenolic plant natural
product dihydrocucurbitacin F-25-O-acetate. The metabolic profile of S. aureus treated with
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dihydrocucurbitacin F-25-O-acetate clustered with the metabolic profile of S. aureus treated with
vancomycin, a known inhibitor of peptidoglycan synthesis (Biao-Yi, Yu, & Zeng-Liang, 2008).
A scheme to classify compounds into known mechanisms of action was also recently
used with NMR metabolomics, where a partial least squares discriminant analysis of the
metabolic “fingerprints” of E. coli treated with one of 9 antibiotics of known mechanism gave
91% accuracy with intracellular data and 30% accuracy with extracellular data (Hoerr et al.,
2016). Another systems biology approach similarly classified phenotypes based on the Raman
spectra of dried E. coli cells to distinguish antibacterial mechanisms of action; 15 antibacterial
compounds representing protein synthesis inhibitors, cell wall synthesis inhibitors, DNA
synthesis inhibitors, and RNA synthesis inhibitors were differentiable with 83.6% accuracy by
mechanistic class. Ampicillin was always incorrectly classified with the final model based on a
linear discriminant analysis of principle components, but overlap between the mechanism groups
could explain this and other misclassification tendencies (Athamneh, Alajlouni, Wallace,
Seleem, & Sengera, 2014). Classification schemes like these can only classify data into known
mechanisms of action. However, unknown mechanisms of action should not group into known
mechanistic classes and could thus be singled out for further characterization.
Transcriptomic studies have tended to highlight pathways impacted by an antibacterial
compound without identifying a specific mechanism of action (Yu et al. 2012, Bionda et al.
2013, Elnakady et al. 2016), although transcriptional profiling of bacterial mutants revealed
expression trends that were used to predict phenylalanyl-tRNA synthetase inhibition and
bacterial acetyl coenzyme A carboxylase inhibition as the primary mechanisms of action of two
novel antibacterial compounds (C Freiberg, Fischer, & Brunner, 2005). A 2004 review cites
transcriptomic and proteomic studies that used transcriptomics or proteomics to assess
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antibacterial mechanisms, some of which were successful in identifying mechanisms of action
(Christoph Freiberg, Brötz-Oesterhelt, & Labischinski, 2004). More recently, proteomics showed
its usefulness in mechanistic assessments by providing evidence for a second mechanism of
action of the atypical tetracycline chelocardin, which inhibits peptidyl transferase at low
concentrations and causes membrane depolarization at high concentrations in B. subtilis
(Stepanek, Lukežič, Teichert, Petković, & Bandow, 2016).
Structural systems pharmacology has also made strides in identifying antibacterial
mechanisms through combining multiple -omics approaches. A recent study was able to use an
E. coli K12 genome scale metabolic model integrated with protein structures to correctly predict
the antibacterial mechanisms of fosfomycin, and sulfathiazole. This model was also able to
predict additional mechanisms of action for (1-hydroxyheptane-1,1-diyl)bis(phosphonic acid)
and cholesteryl oleate and predict potential inhibitors of a protein target (tryptophan synthase
beta subunit) with no previously known inhibitors. However, many false positives were also
observed, which could be attributed to the static protein structures used to evaluate ligand
binding (Chang, Xie, Bourne, & Palsson, 2013).
Systems biology approaches in assessments of phenolic antibacterial mechanisms of
action are relatively rare: Nakayama et al. (2015) used proteomics to identify a set of membrane
proteins that epicatechin gallate may inhibit in Bacillus subtilis (Nakayama et al., 2015) while Di
Pasqua et al. (2007) used HRGC to evaluate membrane effects of thymol, carvacrol, and eugenol
and Di Pasqua et al. (2010) used proteomics to identify proteins and pathways altered by thymol.
Conclusion
The mechanisms of action of most naturally derived phenolic compounds are not well
characterized. Of the compounds reviewed here, mechanistic assessments have found specific
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antibacterial targets, including DNA, DNA gyrase, multi-drug efflux pumps, FabZ, protein
kinases, helicase, and FtsZ. The identification of these antibacterial targets through targetdirected methods enables the rational use of phenolic compounds against bacterial pathogens
susceptible to these known mechanisms of action. However, target-directed approaches have no
opportunity to discover novel mechanisms of action, which is a necessary step to combat multidrug resistant bacteria. A systems-biology approach to investigating the antibacterial
mechanisms of phenolic compounds is not yet common in determining phenolic antibacterial
mechanisms of action, but will likely push the field forward by speeding up mechanistic
determinations and removing the bias of testing for currently known mechanisms.
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Appendix
Figures

Figure 2. Antibacterial mechanisms of action summarized for A. common antibiotic classes and
B. plant phenolic compounds (adapted from Helander et al. 1997, Brown et al. 2015,
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Figure 2 legend continued
Kohanski et al. 2010). PBP: penicillin binding protein. Effects of exogenous magnesium were
not tested on a Gram-positive organism, only a Gram-negative organism.

Tables
Table 1. Known antibacterial mechanisms of action of phenolic compounds. (attachment)
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CHAPTER III
COMPUTATIONAL RANKING OF YERBA MATE SMALL MOLECULES
BASED ON THEIR PREDICTED CONTRIBUTION TO ANTIBACTERIAL
ACTIVITY AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS
AUREUS
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Abstract
The aqueous extract of yerba mate, a South American tea beverage made from Ilex
paraguariensis leaves, has demonstrated bactericidal and inhibitory activity against bacterial
pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The gas
chromatography-mass spectrometry (GC-MS) analysis of two unique fractions of yerba mate
aqueous extract revealed 8 identifiable small molecules in those fractions with antimicrobial
activity. For a more comprehensive analysis, a data analysis pipeline was assembled to prioritize
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compounds for antimicrobial testing against both MRSA and methicillin-sensitive S. aureus
using forty-two unique fractions of the tea extract that were generated in duplicate, assayed for
activity, and analyzed with GC-MS. As validation of our automated analysis, we checked our
predicted active compounds for activity in literature references and used authentic standards to
test for antimicrobial activity. 3,4-dihydroxybenzaldehyde showed the most antibacterial activity
against MRSA at low concentrations in our bioassays. In addition, quinic acid and quercetin
were identified using random forests analysis and 5-hydroxy pipecolic acid was identified using
linear discriminant analysis. We also generated a ranked list of unidentified compounds that may
contribute to the antimicrobial activity of yerba mate against MRSA. Here we utilized GC-MS
data to implement an automated analysis that resulted in a ranked list of compounds that likely
contribute to the antimicrobial activity of aqueous yerba mate extract against MRSA.
Introduction
Antibiotic resistance is a significant problem for human and animal health since the development
and production of novel antimicrobials has lagged behind the evolution of bacteria for multi-drug
resistance. Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogenic biotype of
global concern because of its resistance to multiple antibiotics (World Health Organization,
2014). Bioactive plant compounds are a potential source for novel antimicrobial formulations;
however, the isolation and identification of a novel antimicrobial component among hundreds of
compounds can be costly and time-consuming. Therefore, a prioritization of compounds based
on bioactivity is a useful first step of an efficient antimicrobial discovery process.
Recent reports have shown that an aqueous extract of yerba mate tea, from the plant Ilex
paraguariensis, is bactericidal and inhibitory to the growth of bacterial pathogens (Burris et al.,
2011; Burris, Davidson, Stewart, Zivanovic, & Harte, 2012), including MRSA (Burris et al.,
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2015) and could contain one or more novel antimicrobial compounds. Although many compound
classes could contribute to antimicrobial activity, this study focused on compounds, like
phenolics, that are readily detected with gas chromatography-mass spectrometry (GC-MS) when
derivitized with trimethylsilyl (TMS) groups. Small phenolic molecules are known to be
prevalent in yerba mate (Heck & de Mejia, 2007) and have antimicrobial activity against many
pathogens, including MRSA (reviewed in Cowan, 1999; Saleem et al., 2010), and so serve as a
reasonable initial focus in the search for yerba mate antimicrobial constituents. Phenolics
previously observed in extracts of yerba mate tea include caffeic acid, caffeoylquinates,
caffeoylshikimates, dicaffeoylquinates, feruloylquinates, kaempferol, quercetin, and rutin, which
have been observed to have beneficial properties ranging from antioxidant to antitumor activities
(reviewed in Heck and de Mejia, 2007). Recently, MRSA-antimicrobial activity of yerba mate
was characterized (Burris et al., 2015; Martin et al., 2013). In addition, Martin et al. 2013
identified chlorogenic acid and caffeic acid in the yerba mate extracts to be active against
bacterial food pathogens, however, these compounds were not tested against MRSA.
The purpose of our study was to isolate and identify the compounds contributing to yerba
mate’s antimicrobial activity against MRSA. This study expanded on previous assessments by
both identifying compounds with antimicrobial activity against MRSA using a unique assembly
of existing methods and testing authentic standards.
Materials and methods
Yerba mate extractions
Dried leaves of a single commercial brand of yerba mate tea (Taragui; Argentina; 100% leaves;
I. paraguariensis) were purchased from a local international supermarket. Extracts were obtained
using previous methods (Burris et al., 2012) with modifications. Commercial tea leaves were
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finely ground to a particle size of less than 300 µm using a commercial food blender (Oster,
Boca Raton, Fla., USA). Sterile deionized water was added to ground leaves at a ratio of 3.6 ml
to 1 g ground tissue, was allowed to stand for 2 h at 4 °C with occasional mixing to maximize
extraction and was subsequently centrifuged at 5000 × g for 30 min. Aqueous extracts were then
subjected to dialysis at 4 °C against deionized water for 36 h using a 3500 MWCO SnakeSkin
pleated dialysis tubing (ThermoFisher Scientific, Rockford, Ill., USA). Dialyzed extracts were
then centrifuged at 5000 × g for 30 min to remove large insoluble particles and frozen at -80 °C.
Frozen extracts were lyophilized using Labconco FreeZone 12 L Freeze Dry System (Labconco,
Kansas City, Missouri, USA) to concentrate them. Lyophilized extracts were stored at room
temperature in a sealed container until testing.
The lyophilized aqueous extract was subsequently extracted with 10%, 20%, 30%, 40%,
50%, 60%, 70%, 80%, and 90% solvent (methanol or acetonitrile). Following solvent extraction,
samples were centrifuged at 13,000 × g for 30 min which separated them into two fractions: the
pellet (not soluble in solvent concentration) and the supernatant (soluble in solvent
concentration). Fractions were subsequently dried using a SpeedVac Concentrator (Savant
Industries, Inc., Farmingdale, N.Y., USA). Lyophilized solvent-extracts were weighed,
resuspended in sterile water to a concentration of 40 mg/ml and stored at -20 °C until testing.
The GC-MS chromatograms of one initial active and one inactive methanol extract were used to
select compounds found in the active extract but absent in the inactive extract, and likely to
contribute to antibacterial activity (sugars were not selected).
Antimicrobial susceptibility tests
MRSA strains ATCC 33591 and ATCC 33593 were purchased from American Type Culture
Collection (ATCC; Manassas, Va., USA). Methicillin-sensitive Staphylococcus aureus (SA)
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strains ATCC 27708 and SA 113 were obtained from the Center Environmental Biotechnology
at the University of Tennessee, Knoxville (courtesy of Steven Ripp). Bacteria were selected on
Baird-Parker medium (Becton, Dickinson and Co., Sparks, Md., USA) and stock cultures were
prepared by isolating a single colony, growing in tryptic soy broth (TSB; Becton, Dickinson and
Co.) and stored at -20 °C in glycerol.
Solvent extracts were tested for antimicrobial activity by the disk diffusion method
against MRSA and non-resistant S. aureus (SA). Pure cultures of each bacterial strain were subcultured at least once in Mueller-Hinton broth (Becton Dickinson & Co.) by inoculating 50 ml
broth with 200 µl stock cultures for 24 h incubation at 35-37 °C. Following incubation, ca. 9.0
log10 CFU/ml cultures were diluted to ca. 6.0 log10 CFU/ml and each diluted bacterial suspension
was swabbed onto Mueller-Hinton agar plates prior to disk placement. Twenty microliters of the
extract or water control were placed on each 6 mm sterile blank disk (Becton Dickinson & Co.),
and subsequently plated in duplicate on Mueller-Hinton agar. Plates were incubated for 24 h at
37 °C and the zones of inhibition of bacteria were measured.
Two sets of activity assays were performed with authentic standards. The first used
concentrations based on the approximated ratios of compounds observed in our initial twosample GC-MS data (glycolic acid 1 µg/ml, 3,4-dihydroxybenzaldehyde 0.01 µg/ml, citric acid
31 µg/ml , caffeic acid 46 µg/ml, kaempferol 2 µg/ml, chlorogenic acid 285 µg/ml, 4-Ocaffeoylquinic acid 210 µg/ml, 5-O-caffeoylquinic acid 311 µg/ml, and each of these
concentrations at 10x). The second set of activity assays tested compounds alone at 10 µg/ml, 20
µg/ml, and 100 µg/ml. Activity assays for authentic standards alone and in combination were
carried out using a micro-broth dilution assay. Sterile 96-well microtiter plates with a well
capacity of 300 µl were used. A total volume of 250 µl was used consisting of 125 µl double
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strength tryptic soy broth (TSB), 10 µl chemical diluted in 1% dimethyl sulfoxide (DMSO) in
water, and 25 µl of inoculum (ca. 6.0 log10 CFU/mL). For the second set of activity assays,
samples were randomly assigned within central, intermediate, and edge locations on each plate to
minimize edge effects. Only center samples were used in the final analysis. For all tests,
microtiter plates were covered with a sterile lid and incubated for 24 h to 48 h at 37 oC and the
absorbance (630 nm) of each well was read at 0 h, 8 h, 24 h, and 48 h (for the second bioassay)
with a microtiter plate spectrophotometer (Elx800 Universal Microplate reader, BioTek
Instruments, Winooski, Vermont, USA). The micro-broth dilution assays were performed in
triplicate. Statistical analysis of the data was performed using analysis of variance with mixed
models in SAS 9.4 (SAS Institute Inc., Cary, N.C., USA) using a randomized block design
(RBD) blocked on replicate for each single strain separately at 48 h or 24 h. Least squares means
were separated using Tukey’s significant difference test. Levene tests for equal variance
(P>0.05) and Shapiro-Wilks tests for normality (W>0.80) were performed using R, and boxplots
were constructed (R Foundation for Statistical Computing, Vienna, Austria).
GC-MS sample preparation and instrument parameters
The samples rehydrated to 40 mg/ml were filtered using 0.2 µm nylon membrane filters (13 mm
Acrodisc; Pall Corporation, Ann Arbor, Mich., USA). Fifty microliters of each sample (or the
whole sample if less than 50 µl) and 15 µl of 1 mg/ml liquid sorbitol solution were then dried
under a stream of sterile flowing nitrogen. Two samples that contained < 50 µl were multiplied
by a correction factor after feature detection and retention time correction to approximate a 50 µl
sample. Several samples contained insufficient material for rehydration, filtration, and
derivitization. We analyzed a total of 60 samples by GC-MS, 34 of which were unique (some
biological duplicates generated different amounts of material). Dried samples were derivitized by
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adding 500 µl HPLC grade acetonitrile followed by 500 µl N-methyl-Ntrimethylsilyltrifluoroacetamide (MSTFA) with 1% trimethylchlorosilane (TMCS) (Thermo
Fisher Scientific) and incubating at 70 °C for 60 min. After 2 d, 1 µl of each sample was injected
by an autosampler into a GC-MS instrument (Agilent Technologies Inc., Santa Clara, Calif.,
USA) with a 5975C inert XL gas chromatograph-mass spectrometer, fitted with an Rtx-5MS
with Integra-guard (5% diphenyl/95% dimethyl polysiloxane) capillary column 30 m by 250 µm
by 0.25 µm of film thickness). This standard quadrupole GC-MS was operated with electron
impact (EI) ionization at 70 eV, six 50 Da to 650 Da scans per second, and helium gas flow rate
of 1.33 ml/min with the injection port in splitless mode. Temperatures were held at 250 °C for
the injection port, 230 °C for the mass spectrometer source, and 150 °C for the mass
spectrometer quad. The oven was programmed to start at 50 °C for 2 min, ramp up to 325 °C at
20 °C per min, hold for 11 min, and then cycle back down to 50 °C. Data files were exported to
AIA format in MSD ChemStation (Agilent Technologies, Inc., Santa Clara, Calif, USA) for
subsequent analysis.
Data analysis
In an initial assessment of methanolic fractions of yerba mate extract, we selected two
comparable samples, one with antimicrobial activity against MRSA and one without
antimicrobial activity against MRSA, for GC-MS analysis. The resulting spectra were overlayed
and GC peaks that were higher in the active samples and lower in the inactive samples were
identified with the aid of MS libraries when possible.
The software program XCMS (C. A. Smith, Want, O’Maille, Abagyan, & Siuzdak, 2006)
was used for both feature detection and retention time correction with parameters based on the
“GC –EI, Single Quadrupole MS” default values from XCMSOnline (Gowda et al., 2014;
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Tautenhahn & Patti, 2012). The effectiveness of the feature detection of different parameter sets
was assessed by plotting detected features onto a heatmap of a single sample with all known
reference compounds present (Figure S 1). The presence of features at particular reference ions
of known compounds was assessed alongside general trends of the heatmap topology in order to
select optimal parameters. The same method was used to evaluate the effectiveness of correcting
retention time drift by plotting corrected features and uncorrected features on the same single
sample heatmap. Final feature detection and retention time correction parameters for XCMS are
listed in Table S 1. Correction factors for the 2 samples with concentrations less than 50 µl were
multiplied by intensity values to create a modified matrix that was used for all subsequent
analyses. There was variation in the sorbitol (internal standard) 319 m/z peak height relative to
the intensities of other peaks in some samples, which was likely the result of ion suppression
and/or sample matrix interactions. Therefore, spectral peaks were further adjusted based on the
319 m/z peak of sorbitol, so that adjusted ion peak = ion peak * average sorbitol 319 m/z peak
across all spectra/sorbitol 319 m/z peak of current spectrum.
Linear discriminant analysis (LDA) was implemented as a pseudo-inverse matrix
calculation using the Python linear algebra library numpy.linalg.pinv. The data matrix from
XCMS was normalized by subtracting the mean and dividing by the standard deviation for each
attribute column. To construct a proper discriminant function, a 'bias' feature was added in the
form of a column of ones. With this, the Python Numpy pseudo-inverse function was used to
train and test the data with leave-one-out cross-validation sets. Finally, the whole dataset was
used in training to generate an optimized weight for each attribute. The weight coefficient for
each attribute in the discriminant function can be seen as an estimate of that attribute's
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importance in computing the antimicrobial activity. Hence, attributes were ranked from largest to
smallest weight and assessed for the numbers of known antimicrobial compounds with high rank.
MetaboAnalyst was used to generate additional ranked peaklists using different methods. Using
MetaboAnalyst software (Xia, Mandal, Sinelnikov, Broadhurst, & Wishart, 2012), we prioritized
peaks in ranked lists from fold-change analysis (using proportions of change between two
sample groups), t-test (using comparison of means between two groups), principal component
analysis (PCA; using an unsupervised measure across data axis with the most spread), partial
least squares linear discriminant analysis (PLS-DA; using a supervised measure across data axes
with most variation), recursive support vector machine (R-SVM; using the supervised dataseparating hyperplanes of several SVMs to rank the top 50 attributes from the t-test),
significance analysis of microarray (SAM; using significance scores and thresholds to determine
the significance of single features), empirical Bayesian analysis of microarray (EBAM; using a
two group mixture model to separate null and significant features based on a delta value of 0.9),
and random forests (using set of weak decision tree learners which form a strong voting system
for classification) analyses. MetaboAnalyst parameters for no missing data and autoscaling for
normalization were selected.
Lists from PCA were ordered from largest to smallest absolute values of the first
principal component loading values to assess an unsupervised approach. PLS-DA, LDA, and
random forests lists were ordered from largest to smallest (not absolute value) since they were
supervised, and positive values were associated with attributes that discriminated the positive
class (active) from the negative class (inactive). Lists from statistical tests were kept in order of
statistical significance (smallest to largest p-values (t-test), smallest to largest log2s (fold
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change), largest to smallest z-values (EBAM), and largest to smallest d-values (SAM)). Ranking
weights and statistical values are reported in Table S 2.
JMP Pro 10 (SAS Institute Inc., Cary, N.C., USA 1989-2007) was used to run logistic regression
analyses on the top-ranked spectral peaks of quinic acid, quercetin, and 5-hydroxy-pipecolic acid
using peak intensity as a continuous variable to predict a binary outcome of inactive or active
against MRSA. Each model was evaluated based on the whole model test Prob<ChiSq p-value
and lack of fit Prob<ChiSq p-value being less than 0.05. The parameter estimate of the model
was then used to reverse predict the classes of the dataset based on the spectral peak to get a
predictive accuracy.
Prioritized peak lists were compared in a pairwise fashion using a rank biased overlap
function implemented with the Python function rbo.py (Agrawal, 2013; Webber, Moffat, &
Zobel, 2010). This function scored the similarity between the single top-ranked element of each
list, then scored the similarity between the top two-ranked elements of each list, and so on, in
overlapping sections to generate an overall score. These scores gave greater weight to the more
highly ranked elements by using a convergent series of weights, specifically the geometric series
(Webber et al., 2010).
The Golm Metabolome Database (GMD) was used to predict functional groups for
unknown compounds. Each functional group had its own decision tree classifier with a crossvalidation accuracy obtained from the GMD (Hummel, Strehmel, Selbig, Walther, & Kopka,
2010) that was used to gauge predictive accuracy. The Python library urllib2 was used to
interface with the GMD in an automated fashion.
Retention index was calculated from a best-fit line of known compounds based on their
retention indices in GMD GC-EI-TMS spectra, and their retention times in our data. This
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calculation was devised from the knowledge that any set of compounds with known retention
indices can be used to index other compounds from the same spectra (Ettre, 2003). Predicted
functional groups were summarized for each dataset compilation by counting occurrences of
each unique predicted group for all unique retention times and for the top ten unique retention
times.
Results
Yerba mate extracts fractionated by varying proportions of acetonitrile (Table S 3) or methanol
(Table S 4) in water had variable activity against MRSA and SA. In general, fractions with
higher antimicrobial activity were observed in supernatants extracted with 80% or less methanol
and 70% or less acetonitrile and in the pellets remaining from the extractions using higher
percent methanol (>80%) (Table S 4) or acetonitrile (>70%) fractions (Table S 3). The resulting
activity data was used to label each fraction as ‘active’ (any measure of bacterial growth
inhibition) or ‘inactive’ (no bacterial growth inhibition) (Table S 3, Table S 4).
Our initial GC-MS analysis of one spectrum from an antibacterial extract and one
spectrum from a non-antibacterial extract generated a differential list of 8 non-carbohydrate
compounds (Figure 3), 4 of which were already known to inhibit MRSA, based on literature
sources (Table S 5). For our automated spectral analysis of a more robust dataset, our feature
detection parameters with XCMS resulted in 2204 m/z peaks at unique retention times. Visual
examination of detected features on a m/z vs. retention time heatmap (Figure S 1) revealed that
features generally aligned well with high intensity m/z regions of the heatmap. A check for the
existence of major ions from our 8 known compounds showed that at least one major ion peak
from caffeic acid, citric acid, and the chlorogenic acids was present. The extracted ion peaks our
group used for 3,4-dihydroxybenzaldehyde and kaempferol were not detected, but other
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characteristic peaks of these compounds were observed at their respective retention times. Peaks
for glycolic acid were not detected.
In a check for proper retention time correction, features from two different sampling time
periods were visually observed to improve based on overlays before and after retention time
correction plotted on a sample heatmap (Figure S 1). Although there was significant
improvement, retention time drift correction could still be improved further, as evidenced by
non-overlapping dots in the corrected plot.
In general, spectra from extracts of different solvent fractionation methods contained
many of the same GC peaks, so differences in quantitative information were more relevant to this
analysis than differences in qualitative information. The ability to rank influential compounds
would be improved and perhaps more reliable with fractionation methods that generated extracts
with very qualitatively different compositions. Nevertheless, our analysis of this dataset revealed
an additional set of three identifiable, and potentially antibacterial, compounds (quinic acid,
quercetin, and 5-hydroxy-pipecolic acid) in addition to the unknown compounds that ranked with
known antimicrobials. Since the list ranked by random forests contained the most antimicrobial
compounds that were known in high ranks, we additionally surveyed compounds at ranks
between 10 and 20. We identified one unknown (rank 13) compound predicted to be aromatic in
the 10-20 ranks of the random forests list. This unknown compound would be of interest to
further characterize as a potential novel antimicrobial (Table 2). In our analysis of activity
against just SA, 3-O-feruloylquinic acid was identified as an additional compound of interest.
We evaluated the following eight pure compounds that were identified in our initial GCMS data overlay for antimicrobial activity alone and in selected combinations at concentrations
based on GC-MS quantification (in sorbitol equivalents) to assess approximate antimicrobial
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ratios of the compounds: citric acid, caffeic acid, 3,4-dihydroxybenzaldehyde, 3-Ocaffeoylquinic acid (chlorogenic acid), 4-O-caffeoylquinic acid, 5-O-caffeoylquinic acid,
kaempferol, and glycolic acid. We observed a significant reduction (P<0.05) in means relative to
a positive growth control sample (mean of 0.99 absorbance units, standard error of mean (SE)
0.08) with caffeic acid at 460 µg/ml (0.62 absorbance units, SE 0.08) with SA 27708. We also
observed a significant reduction (P<0.05) in means relative to a positive growth control sample
(0.87 absorbance units, SE 0.05) with MRSA 33593 for 3,4-dihydroxybenzaldehyde at 0.01
µg/ml (0.70 absorbance units, SE 0.05), glycolic acid at 1 µg/ml (0.66 absorbance units, SE
0.05), and caffeic acid at both 46 µg/ml (0.73 absorbance units, SE 0.05) and 460 µg/ml (0.72
absorbance units, SE 0.05). Of our selected combinations of compounds, only the sample
containing the combination of most components (caffeic acid, citric acid, 3,4dihydroxybenzaldehyde, chlorogenic acid, kaempferol, and glycolic acid at 10x concentrations
listed in Figure 3) showed antimicrobial activity (0.55 absorbance units, SE 0.05) against
MRSA, and only against MRSA 33593 (Figure 4).
Each of the previously-identified compounds were also tested at concentrations of 10
µg/ml, 20 µg/ml, and 100 µg/ml, although only 3,4-dihydroxybenzaldehyde was observed to
significantly reduce MRSA growth (from positive control mean of 0.74 absorbance units, SE
0.03, to 0.66 absorbance units, SE 0.03), and only at 100 µg/ml (Figure 5). Assumptions of
normality, equal variance, and no block-by-treatment interaction were upheld with the exception
of SA 113 (Figure 5A), in which a significant block-by-treatment interaction was observed (P <
0.05), which meant that no conclusion could be drawn from Figure 5A.
A total of 12 ranked peak lists were produced using statistical tests and classification
analyses from MetaboAnalyst software and LDA. Among the lists generated by supervised
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learning (PLS-DA, random forests, LDA), the accuracies were similar, with an accuracy of 0.83
for both LDA and random forests with the MRSA data, and accuracies of 0.86 for SA LDA and
0.80 for SA RF. PLS-DA had an accuracy of 0.77 for both MRSA and SA (confusion matrices in
Table S 6). There was no obvious similarity between misclassified samples, although several
samples had relatively low intensities.
The relationship between result lists from different classification methods was assessed
using a rank biased overlap analysis (Webber et al., 2010) and are summarized in Table 3. The
lists generated by t-test, SAM, and EBAM were nearly identical (RBO > 0.99 similarity), so only
the t-test list is displayed in Table 4. PCA, fold-change, and SVM lists were most different from
each other and other lists (RBO < 0.1). The fold-change list was additionally noted to contain
many derivitization artifacts with high rank (7 of the top 10 were derivitization artifacts).
Random forests, PLS-DA, and t-test results were more similar to each other with RBO values
ranging from 0.2 to 0.6 (RBO similarity scale 0 to 1, 1 = identical). Many of the same
compounds appeared in the top 10 elements of each list, summarized in Table 4. These
compounds included citric acid, 3-O-caffeoylquinic acid, 4-O-caffeoylquinic acid, caffeic acid,
quinic acid, quercetin, and unknown compounds (retention times and major m/z peaks listed in
Table 4).
Contributions of the newly-identified potential antimicrobial compounds quinic acid,
quercetin, and 5-hydroxy-pipecolic acid were further assessed with a logistic regression analysis
of a single representative m/z peak for each. Using m/z peaks 537, 471, and 244 for quinic acid,
quercetin, and 5-hydroxy-pipecolic acid, respectively, we evaluated the area under receiver
operating characteristic (ROC) curves for the logistic regression analysis of each compound
(Table 5). The area under the ROC curve followed the ranked order of the compounds with
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quinic acid at 0.86, quercetin at 0.78, and 5-hydroxy-pipecolic acid at 0.72. All of these values
are > 0.50, and so there exists some predictive ability over random chance.
Additional compounds that could not be identified might also contribute to antimicrobial
activity. To gain further information about the highly-ranked unknown compounds, functional
groups were predicted by GMD decision trees for the fragments detected at each unique retention
time in the random forests list (Table 6, Table 7). For the 315 unique retention times found in our
dataset, the major predicted functional groups were carboxylic acid derivatives (228), alpha
amino acids (106), aromatics (119), and carboxylic acids (292) (Table 5). Of particular interest
was the unknown compound in the random forests top-10 list, but the GMD decision trees
predicted it to be a carboxylic acid and a carboxylic acid derivative rather than a functional group
commonly associated with antibacterial activity. In examining the top-20 list from random
forests, we found an unknown compound (rank 13) that was predicted to contain an aromatic
group that would be of interest for further characterization as a potentially novel antimicrobial
compound (Table 2).
The reliability of these functional group predictions was based on the “VAR5” crossvalidation assessment of each training model done by the Golm group (Hummel et al., 2010),
with the resulting functional group predictions having an F-measure threshold of at least 0.65
based on a precision-recall plot (Hummel et al., 2010). The predicted functional group crossvalidation error was 13.54% for “hydroxy“, 9.65% for “aromatic”, and 3.31% for “phenol”
groups (Hummel et al., 2010).
Discussion
Hyphenated chromatography-mass spectrometry techniques have yielded a number of
downstream data analysis pipelines (reviewed in Hoffmann and Stoye, 2012), from which we
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implemented functions from XCMS, MetaboAnalyst, and Python’s Numpy. We obtained GCMS data for 60 fractions of aqueous yerba mate extract (including biological duplicates) and
monitored the data-processing steps of XCMS. Since each fraction had a known bioactivity
against MRSA, we computationally predicted compounds with significant contribution to the
grouping, or class, of ‘active’ fractions and then assessed the classification using MICs found in
the literature, as well as our own set of bioassays using authentic standards.
In our first bioassay, we aimed to assess the effect of key compounds alone and in
combination using concentrations that approximated the relative content of compounds that were
visible using GC-MS. We observed caffeic acid to be inhibitory at 46 µg/ml, which is similar to
the 62.5 µg/ml previously observed for caffeic acid against SA, but smaller than the minimum
inhibitory concentration (MIC) of 240 µg/ml reported against MRSA (Luís, Silva, Sousa, Duarte,
& Domingues, 2014). Citric acid and chlorogenic acid were previously shown to have MICs of
900 µg/ml (Nagoba, Gandhi, Wadher, Potekar, & Kolhe, 2008) and 500 µg/ml or higher (Alves
et al., 2013; Luís et al., 2014; Su, Ma, Wen, Wang, & Zhang, 2014) for MRSA, respectively,
although we did not observe these compounds to inhibit MRSA. We did observe the inhibition of
MRSA by glycolic acid at 1 µg/ml, which is in the activity range of bacterial antibiotics (Tegos
& Stermitz, 2002). However, glycolic acid was not found with our peak detection parameters,
and so was not included in our peak ranking analysis or second bioassay. Kaempferol and
quercetin were previously observed to be active against MRSA at pharmacologically-relevant
concentrations of 13 µg/ml (Hazni, Ahmad, Hitotsuyanagi, Takeya, & Choo, 2008) and from 10
µg/ml to 125 µg/ml (Rodríguez Vaquero, Alberto, & Manca de Nadra, 2007; Su et al., 2014),
respectively. However, we observed no significant growth inhibition for kaempferol or quercetin
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against MRSA at these concentrations (Figure 5). This lack of inhibition might result from the
incomplete solubilization in 1% DMSO and, thus, loss of chemicals during filtration.
A major challenge of analyzing GC-MS data is dealing with the large number of
attributes relative to the small number of samples. Data with more attributes than samples are
easily overfit by nonlinear methods, so linear analysis methods are preferred. Since the purpose
of the automated analysis was to rank attributes by their contribution to antimicrobial activity,
we required a method capable of classifying and ranking samples. After a pre-processing step of
feature detection and correction using XCMS software, we found that LDA was a method that fit
both of these requirements, which has already been implemented in studies of mass spectral
analysis (Covington et al., 2013; Santos, Nardini, Cunha, Barbosa, & De Almeida Teixeira,
2014). MetaboAnalyst software also hosts a set of easily implemented techniques for the
comparative analysis of mass spectral data that resulted in useful comparisons with LDA. This
work suggested that LDA did not do well at prioritizing antimicrobial compounds with our data
since none of the known antimicrobial compounds were ranked in the top-10 list (Table 4). The
limitations of LDA with highly collinear data could have contributed to its poor rankings, as
suggested previously (Varmuza, He, & Fang, 2003). Random forests classification implemented
with MetaboAnalyst did, however, prioritize antimicrobial compounds well, ranking 4 of the
known antimicrobials in the top-10 list. The superiority of random forests over SVM and LDA in
a GC-MS classification application was previously observed (Chen et al., 2013). Despite this
apparent success of MetaboAnalyst’s random forests implementation, it also identified sugars in
the top-10 list. This occurred in other lists too, as well as did derivization artifacts, or peaks that
were present in the derivitization blank.
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The highly-ranked matches to sugar compounds that we observed with multiple methods
likely resulted from a coincidental correlation of sugar concentration with the yerba mate
fractions observed to have antimicrobial activity. There are background sugar peaks at many
unique retention times that could be glycosides attached to the active components we have
identified, but the data generated did not give enough information to categorize them as
glycosides or background sugar peaks. It is interesting to note that the presence of sugar has been
observed to promote the activity of antimicrobial compounds (Allison, Brynildsen, & Collins,
2011).
Of the potential anti-MRSA compounds identified by our analysis that we were unable to
experimentally test, 5-hydroxy-pipecolic acid and 3-O-feruloylquinic acid have strong potential
for antimicrobial activity as hydroxylated phenolic compounds, even though we did not find any
literature in which these compounds have been tested against MRSA. Quinic acid is a common
plant metabolite in the shikimic acid pathway that has been reported to have antimicrobial
activity against SA at 16 µg/ml, but it was not observed to have activity against MRSA at
concentrations up to 28 µg/ml (Ozçelik, Kartal, & Orhan, 2011).
In the top-10 unique retention times predicted by random forests, there were an additional
two aromatic, phenol, and hydroxyl groups predicted in the MRSA data over the SA data (Table
6). This identification suggests that aromatic and hydroxylated groups may play a role in the
MRSA antimicrobial activity of the active fraction, although further analysis would be required
to test this hypothesis. Aromatic compounds have antimicrobial activity dependant on hydroxyl
groups (reviewed in Saleem et al., 2010)), including derivatives of caffeic acid and
caffeoylquinics, which have previously been observed to inhibit MRSA (Luís et al., 2014).
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Conclusion
The increasing resistance of MRSA to existing antimicrobials demands the development of new
antimicrobial options. Here we have assembled a pipeline that took advantage of the large
amounts of data generated by GC-MS by implementing existing GC-MS tools for an automated
analysis that resulted in a ranked list of compounds likely to contribute to the antimicrobial
activity of aqueous yerba mate extract against MRSA. We tested the results of this analysis by
assaying the antimicrobial activity of pure compounds at a pharmacologically-relevant
concentration. 3,4-dihydroxybenzaldehyde was the only compound we assayed with activity at a
concentration of 100 µg/ml or less. We also determined that 5-hydroxy-pipecolic acid, quercetin,
quinic acid, and one unidentified compound could be possible contributors to yerba mate
antimicrobial activity against MRSA using LDA and a random forests analysis. The unique
combination of existing methods and tools used in this study generated prioritized lists of
compounds likely to contribute to the antimicrobial activity of yerba mate extract, of which citric
acid, caffeic acid, chlorogenic acid, kaempferol, quercetin were observed to inhibit MRSA in
previous studies (Fattouch & Caboni, 2007; Hazni et al., 2008; Hirai et al., 2010; Luís et al.,
2014; Nagoba et al., 2008; Su et al., 2014). 5-hydroxy pipecolic acid, 3-O-feruloylquinic acid,
and the unknown compound ranked 13 from the random forests list would be useful for further
characterization in order to understand which natural compounds in yerba mate might serve as
useful antimicrobials against both MRSA and SA.
Acknowledgements
We would like to thank Nancy Engle (NLE) at ORNL for her assistance with and advice for
running GC-MS. We thank Steven Ripp for sharing bacteria strains. This research was
supported by SCALE-IT IGERT NSF IRE, the Ivan Racheff Chair of Excellence endowment,

54
and the Tennessee Agricultural Experiment Station. TJT and NLE were supported by the
Genomic Science Program (project ‘Plant-Microbe Interactions’), U.S. Department of Energy,
Office of Science, Biological and Environmental Research under the contract DE-AC0500OR22725.

55

References
Agrawal, R., 2013. rbo.py.
Allison, K., Brynildsen, M., Collins, J., 2011. Metabolite-enabled eradication of bacterial
persisters by aminoglycosides. Nature 473, 216–220.
Alves, M.J., Ferreira, I.C.F.R., Froufe, H.J.C., Abreu, R.M. V, Martins, a, Pintado, M., 2013.
Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis
and docking studies. J. Appl. Microbiol. 115, 346–57.
Burris, K.P., Davidson, P.M., Stewart, C.N., Harte, F.M., 2011. Antimicrobial activity of yerba
mate (Ilex paraguariensis) aqueous extracts against Escherichia coli O157:H7 and
Staphylococcus aureus. J. Food Sci. 76, M456–62.
Burris, K.P., Davidson, P.M., Stewart, C.N., Zivanovic, S., Harte, F.M., 2012. Aqueous extracts
of yerba mate (Ilex paraguariensis) as a natural antimicrobial against Escherichia coli
O157:H7 in a microbiological medium and pH 6.0 apple juice. J. Food Prot. 75, 753–7.
Burris, K.P., Higginbotham, K.L., Stewart, C.N., 2015. Aqueous extracts of yerba mate as
bactericidal agents against methicillin-resistant Staphylococcus aureus in a microbiological
medium and ground beef mixtures. Food Control 50, 748–753.
Chen, T., Cao, Y., Zhang, Y., Liu, J., Bao, Y., Wang, C., Jia, W., Zhao, A., 2013. Random forest
in clinical metabolomics for phenotypic discrimination and biomarker selection. Evidencebased Complement. Altern. Med. 2013, 1–11.
Covington, J.A., Westenbrink, E.W., Ouaret, N., Harbord, R., Bailey, C., O’Connell, N., Cullis,
J., Williams, N., Nwokolo, C.U., Bardhan, K.D., Arasaradnam, R.P., 2013. Application of a
novel tool for diagnosing bile acid diarrhoea. Sensors 13, 11899–912.
Cowan, M.M., 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12, 564–82.
Ettre, L.S., 2003. Retention Index Expressions. Chromatographia 58, 491–494.
Fattouch, S., Caboni, P., 2007. Antimicrobial activity of Tunisian quince (Cydonia oblonga
Miller) pulp and peel polyphenolic extracts. J. Agric. Food Chem. 55, 963–969.
Gowda, H., Ivanisevic, J., Johnson, C.H., Kurczy, M.E., Benton, H.P., Rinehart, D., Nguyen, T.,
Ray, J., Kuehl, J., Arevalo, B., Westenskow, P.D., Wang, J., Arkin, A.P., Deutschbauer,
A.M., Patti, G.J., Siuzdak, G., 2014. Interactive XCMS Online: simplifying advanced
metabolomic data processing and subsequent statistical analyses. Anal. Chem. 86, 6931–9.
Hazni, H., Ahmad, N., Hitotsuyanagi, Y., Takeya, K., Choo, C.Y., 2008. Phytochemical
constituents from Cassia alata with inhibition against methicillin-resistant Staphylococcus
aureus (MRSA). Planta Med. 74, 1802–1805.
Heck, C.I., de Mejia, E.G., 2007. Yerba Mate Tea (Ilex paraguariensis): a comprehensive review
on chemistry, health implications, and technological considerations. J. Food Sci. 72, R138–
51.
Hirai, I., Okuno, M., Katsuma, R., Arita, N., Tachibana, M., Yamamoto, Y., 2010.
Characterisation of anti-Staphylococcus aureus activity of quercetin. Int. J. Food Sci.
Technol. 45, 1250–1254.

56
Hoffmann, N., Stoye, J., 2012. Generic software frameworks for GC-MS based metabolomics.
In: Roessner, D.U. (Ed.), Metabolomics. InTech, Rijeka, pp. 73–98.
Hummel, J., Strehmel, N., Selbig, J., Walther, D., Kopka, J., 2010. Decision tree supported
substructure prediction of metabolites from GC-MS profiles. Metabolomics 6, 322–333.
Luís, Â., Silva, F., Sousa, S., Duarte, A.P., Domingues, F., 2014. Antistaphylococcal and biofilm
inhibitory activities of gallic, caffeic, and chlorogenic acids. Biofouling 30, 69–79.
Martin, J.G.P., Porto, E., Alencar, S.M. De, Glória, E.M., Corrêa, C.B., Cabral, I.S.R., 2013.
Antimicrobial activity of yerba mate (Ilex Paraguariensis St. Hil.) against food pathogens.
Rev. Argent. Microbiol. 45, 93–98.
Nagoba, B.S., Gandhi, R.C., Wadher, B.J., Potekar, R.M., Kolhe, S.M., 2008. Microbiological,
histopathological and clinical changes in chronic infected wounds after citric acid treatment.
J. Med. Microbiol. 57, 681–2.
Ozçelik, B., Kartal, M., Orhan, I., 2011. Cytotoxicity, antiviral and antimicrobial activities of
alkaloids, flavonoids, and phenolic acids. Pharm. Biol. 49, 396–402.
Rodríguez Vaquero, M.J., Alberto, M.R., Manca de Nadra, M.C., 2007. Antibacterial effect of
phenolic compounds from different wines. Food Control 18, 93–101.
Saleem, M., Nazir, M., Ali, M.S., Hussain, H., Lee, Y.S., Riaz, N., Jabbar, A., 2010.
Antimicrobial natural products: an update on future antibiotic drug candidates. Nat. Prod.
Rep. 27, 238–54.
Santos, V.S., Nardini, V., Cunha, L.C., Barbosa, F., De Almeida Teixeira, G.H., 2014.
Identification of species of the Euterpe genus by rare earth elements using inductively
coupled plasma mass spectrometry and linear discriminant analysis. Food Chem. 153, 334–
9.
Smith, C.A., Want, E.J., O’Maille, G., Abagyan, R., Siuzdak, G., 2006. XCMS: processing mass
spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and
identification. Anal. Chem. 78, 779–87.
Su, Y., Ma, L., Wen, Y., Wang, H., Zhang, S., 2014. Studies of the in vitro antibacterial
activities of several polyphenols against clinical isolates of methicillin-resistant
Staphylococcus aureus. Molecules 19, 12630–9.
Tautenhahn, R., Patti, G., 2012. XCMS Online: a web-based platform to process untargeted
metabolomic data. Anal. Chem. 84, 5035–5039.
Tegos, G., Stermitz, F., 2002. Multidrug pump inhibitors uncover remarkable activity of plant
antimicrobials. Antimicrob. Agents Chemother. 46, 3133–3141.
Varmuza, K., He, P., Fang, K., 2003. Boosting applied to classification of mass spectral data. J.
Data Sci. 1, 391–404.
Webber, W., Moffat, A., Zobel, J., 2010. A similarity measure for indefinite rankings. ACM
Trans. Inf. Syst. 28, 1–38.
World Health Organization, 2014. Antimicrobial resistance: global report on surveillance.
Geneva.
Xia, J., Mandal, R., Sinelnikov, I. V, Broadhurst, D., Wishart, D.S., 2012. MetaboAnalyst 2.0--a

57
comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40, W127–33.

58

Appendix
Figures

Figure 3. Overlay of initial yerba mate extract fraction chromatograms. A) The black
chromatogram corresponds to a yerba mate extract fraction that demonstrated antibacterial
activity against methicillin-resistant Staphylococcus aureus (MRSA); the red chromatogram
corresponds to a yerba mate fraction that had no antibacterial activity against MRSA. B)
Retention times of identified compounds and quantification in sorbitol equivalents were reported.
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Figure 4. Growth of methicillin-sensitive (SA) and methicillin-resistant Staphylococcus aureus
(MRSA) in the presence of single or multiple pure compounds at proportions approximated from
GC-MS quantification. Growth with compounds alone or together was compared to the positive
growth control (no chemical added) to determine inhibitory activity. Statistically significant
differences greater (*) or less (**) than control are marked by asterisks. Concentrations follow
the GC-MS quantification values in Figure 3, but in µg/ml. Growth of A. SA 27708, B. MRSA
33591, and C. MRSA 33593 are reported at 24 h.
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Figure 5. Growth of methicillin-sensitive (SA) and methicillin-resistant Staphylococcus aureus
MRSA) in the presence of pure compounds. At concentrations of 10 µg/ml (chemical_1), 20
µg/ml (chemical_2) and 100 µg/ml (chemical_3), growth with compounds was compared to the
positive growth control (no chemical added) to determine inhibitory activity. Statistically
significant differences greater (*) or less (**) than control are marked by asterisks. Growth of A.
SA 113, B. SA 27708, C. MRSA 33591, and D. MRSA 33593 are reported at 48 h. SA113 had a
significant block by treatment interaction, so no conclusions can be drawn from it.
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Tables
Table 2. Top 20 unique retention times ranked by antimicrobial significance against MRSA
using random forests.
Rank

Known Active
Concentration
(µg/ml)
--900
250
--10
125
--500

Major Ion Peaks

Name

1
2
3
4
5
6
7
8

Retention
Time
(min.)
11.44
11.18
12.71
14.92
16.41
16.82
10.8
16.58

147, 255, 345
147, 273
219, 396
147, 217, 361
396, 559
307
394
147, 255, 307, 345

9
10
11

18.03
5.61
10.58

-------

12

16.78

---

103, 129, 204, 217, 361 , 427
144, 158
55, 57, 69, 75, 81, 83, 97, 99,
123, 204, 217
193, 255, 257, 324, 372, 489

Quinic acid
Citric acid
Caffeic acid
Sucrose
Kaempferol
Quercetin
Unknown
3-O-caffeoylquinic
acid
Raffinose
DA
Unknown

13

12.58

---

143

14
15

6.23
5.11

-----

4-O-caffeoylquinic
acid
Unknown, predicted
aromatic
DA
DA

295
59, 86, 100, 133, 160, 174, 175,
221, 223
16
14.47
--_
Unknown
17
15.28
--103, 129, 204, 217, 305, 361
Unknown
18
16.85
--133, 191, 239, 283, 357, 419,
5-O-caffeoylquinic
447
acid
19
10.07
--262
Unknown
20
11.85
--275
DA
Known active concentrations were obtained from either literature or our bioassays.
DA derivitization artifact
--- no known inhibitory concentration found
_ no peaks above cut-off
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Table 3. Rank biased overlap comparison of lists.
Average RBO MRSA
Fold
PCA
Change
PCA
1
3.08E-11
Fold
3.08E-11 1
Change
PLS0.000366 0.011483
DA
SAM
0.000192 0
SVM
0.002276 0
T-test
0.001582 7.34E-06
LDA
0.000109 0.075296
EBAM 0.001605 1.23E-09
RF
0.008998 0.000891
Average RBO SA
Fold
PCA
Change
PCA
1
1.59E-12
Fold
1.59E-12 1
Change
PLS2.95E-05 0.044871
DA
SAM
1.13E-05 0
SVM
6.17E-09 0
T-test
0.000676 3.28E-05
LDA
0.000333 0.098322
EBAM 0.00068 1.86E-11
RF
0.010393 0.001522

PLS-DA

SAM

SVM

T-test

LDA

EBAM

RF

0.000366 0.000192 0.002276 0.001582 0.000109 0.001605 0.008998
0.011483 0

0

7.34E-06 0.075296 1.23E-09 0.000891

1

0.618936 0.05196

0.612391 0.012616 0.612037 0.136071

0.618936
0.05196
0.612391
0.012616
0.612037
0.136071

1
0.002872
0.999874
0.00313
1
0.224733

0.002872
1
0.004933
0.04423
0.004054
0.024031

0.999874
0.004933
1
0.002991
0.999644
0.220768

0.00313
0.04423
0.002991
1
0.002995
0.009479

1
0.004054
0.999644
0.002995
1
0.220807

0.224733
0.024031
0.220768
0.009479
0.220807
1

PLS-DA

SAM

SVM

T-test

LDA

EBAM

RF

2.95E-05 1.13E-05 6.17E-09 0.000676 0.000333 0.00068
0.044871 0

0

0.010393

3.28E-05 0.098322 1.86E-11 0.001522

1

0.395548 0.28188

0.388904 0.081874 0.388895 0.149397

0.395548
0.28188
0.388904
0.081874
0.388895
0.149397

1
0.527674
1
0.015228
1
0.186309

1
0.542135
1
0.0154
0.999991
0.182801

0.527674
1
0.542135
0.051292
0.542135
0.122868

0.015228
0.051292
0.0154
1
0.015403
0.021609

1
0.542135
0.999991
0.015403
1
0.182803

0.186309
0.122868
0.182801
0.021609
0.182803
1
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Table 3 notes continued
Values range from 0, dissimilar, to 1, identical. For comparison between MRSA and SA lists,
rank biased overlap between MRSA RF and SA RF = 0.19; MRSA LDA and SA LDA = 0.057;
PCA = 1; PLS-DA = 0.399; T-test = 0.518, EBAM = 0.518; SVM = 0; Fold Change = 0.63.
Table 4. Top ten results for each attribute ranking method. (attachment)
Table 5. Classification accuracy of a single major mz peak for each of the 3 identified
compounds of interest.
Area under receiver operating characteristics curve
MRSA
SA
quinic acid mz 537
0.83
0.86
quercetin mz 471
0.78
0.78
5-hydroxy-pipecolic acid mz
244
0.72
0.68
Quinic acid, quercetin, and 5-hydroxy-pipecolic acid classification accuracies are reported as the
area under the curve (AUC) of a receiver operating curve (ROC) for the logistic regression of
each single m/z peak MRSA or SA. Accuracy ranges from 0 (no samples accurately classified) to
1 (all samples accurately classified).
Table 6. Predicted functional groups from Golm
Unique Retention Time
All Retention
Counts from
MRSA Top 10 SA Top 10
Times
Carboxylic Acid Deriv
4
6
228
Alkene
0
0
3
Prim Aliph Amine
0
0
3
Alcohol
4
5
18
Alpha Aminoacid
0
0
106
Carbonyl
0
0
1
Prim Amine
0
0
4
Aromatic
5
3
119
Prim Alcohol
1
2
9
Phenol
2
0
3
1 2 Diol
3
2
9
Sec Alcohol
2
3
9
Phosphoric Acid Deriv
0
0
1
Carboxylic Acid
7
7
292
Hydroxy
2
0
10
Acetal
1
0
3
Amine
0
0
3
Summary of predicted functional groups from only the top 10 unique retention times and from
all 315 unique retention times of the random forests ranked list.
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Supporting Information
Supporting figures

Figure S 1. Heatmaps showing feature detection and retention time correction of GC-MS data.
A and B correspond to methicillin-resistant Staphylococcus aureus (MRSA) and C and D
correspond to methicillin-sensitive S. aureus (SA). Blue and red dots are from samples obtained
at different times that are in need of retention time correction. The A and C heatmaps display
data points before retention time correction and the B and D heatmaps display data points after
retention time correction. The complete overlap of blue over red would show perfect retention
time correction.
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Supporting tables

Table S 1. Final parameters implemented with XCMS for feature detection and retention time
correction of mass spectral data.
Feature Detection
XCMS Parameters

Value

Function

method

matchedFilter

snthresh

10

Feature detection method using a matched filter algorithm
that compares two classes of spectra to identify features
Signal to noise threshold

max

100

Max peaks selected per mass chromatogram

step

1.0

bin

2

Step size between masses (increased to match the unit mz
resolution of our instrument)
Steps per bin

mzdiff

1

Minimum difference in mz for peaks with overlapping
retention times

Retention Time Correction
XCMS Parameters

Value

Function

method

peakgroups

missing

2

“well behaved” peak groups are used to calculate retention
time deviation, which is used for alignment
Allowed missing peakgroups

extra

2

Allowed extra peakgroups

smoothing

loess

Loess smoothing method implemented

family

Gaussian

Check for Gaussian fit and symmetry; outlier check

span

0.20

degree of smoothing for regression fitting

group()

Function to group peaks with below parameters

mzwid

1

Width of overlapping mz slices

minfrac

1

Minimum fraction of samples for peak group to be in, in at
least one sample group

minsamp

1

Minimum number of samples for peak group to be in

bw

5 before rtcorr,

Bandwidth of Gaussian smoothing kernel

3 after rtcorr
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Table S 2. Ranking values of top 10 attributes for each ranking method. (attachment)
Table S 3. Antimicrobial activity assays of aqueous yerba mate acetonitrile fractions.
Sample
Sample type
Activity
numbe
(Supernatant)
SA 27708
MRSA 33591
r
A
B
A
B
1
Water super
Active
Active
Active
Active
2
100% MeOH super
Active
None
Active
Active
3
90% MeOH super
Active
None
None
Active
4
80% MeOH super
Active
None
Active
Active
5
70% MeOH super
Active
Active
Active
Active
6
60% MeOH super
Active
Active
Active
Active
7
50% MeOH super
Active
Active
Active
Active
8
40% MeOH super
Active
Active
Active
Active
9
30% MeOH super
Active
Active
Active
Active
10
20% MeOH super
Active
None
Active
Active
11*
Water pellet
None
None
None
None
12
100% MeOH pellet
Active
Active
Active
Active
13
90% MeOH pellet
Active
None
Active
Active
14
80% MeOH pellet
Active
None
None
Active
15
70% MeOH pellet
None
None
None
None
16
60% MeOH pellet
None
None
None
None
17
50% MeOH pellet
Active
Active
None
None
18
40% MeOH pellet
None
None
None
None
19
30% MeOH pellet
Active
None
None
None
20
20% MeOH pellet
Active
Active
None
None
Shaded boxes indicate that not enough extract was obtained to perform bioassays.
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Table S 4. Antimicrobial activity assays of aqueous yerba mate methanol fractions.
Sample
number

Sample type
(Supernatant)

1
2
3
4
5
6
7
8
9
10
11*
12
13*
14
15
16
17
18
19
20
21
22

Water super
10% Acetonitrile super
20% Acetonitrile super
30% Acetonitrile super
40% Acetonitrile super
50% Acetonitrile super
60% Acetonitrile super
70% Acetonitrile super
80% Acetonitrile super
90% Acetonitrile super
100% Acetonitrile super
Water pellet
10% Acetonitrile pellet
20% Acetonitrile pellet
30% Acetonitrile pellet
40% Acetonitrile pellet
50% Acetonitrile pellet
60% Acetonitrile pellet
70% Acetonitrile pellet
80% Acetonitrile pellet
90% Acetonitrile pellet
100% Acetonitrile pellet

Activity
SA 27708
MRSA 33591
A
B
A
B
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
None
Active
Active
Active
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
Active
Active
Active

None
None
None
None
None
None
None
Active
Active
Active

None
None
None
None
Active
Active
Active
None

None
None
None
None
None
Active
Active
None

Shaded boxes indicate that not enough extract was obtained to perform bioassays.
A and B are replicates.
Any size zone of inhibition was considered active.
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Table S 5. Summary of compounds identified as potential antibacterials from GC-MS data and
MIC concentrations against methicillin-sensitive Staphylococcus aureus (SA) and methicillinresistant S. aureus (MRSA) from literature.
Compound
Caffeic acid
Citric acid

SA MIC
62.5 ug/ml
not found

Chlorogenic acid
Kaempferol

200 ug/ml;
500 ug/ml
not found

Quercetin

10 ug/ml

Quinic acid

16 ug/ml

MRSA MIC
250 ug/ml
900 ug/ml;
0.05-0.2 gm%

References
LuÍs et al. 2013
Nagoba et al. 1998;
Thool et al. 2014
Zhu et al. 2004;
LuÍs et al. 2013
Fattouch et al. 2007;
Hazni et al. 2008
Hirai et al. 2010;
Su et al. 2014
Özçelik et al. 2011

500 ug/ml
10 ug/ml;
MIC50 = 13 ug/ml
50uM;
125 ug/ml
>28 ug/ml

Table S 6. Accuracies of classification methods shown in confusion matrices.

MRSA

SA

LDA

RF

LDA

RF

Predicted

Predicted

Predicted

Predicted

-1

1

-1

1

-1

1

-1

1

-1

11

4

-1

9

6

-1

8

10

-1

11

7

1

6

39

1

4

41

1

5

37

1

5

37

PLS-DA
accuracy
0.77

PLS-DA accuracy
0.77
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Table S 7. Predicted functional groups listed for the top 10 compounds with retention time (RT),
retention index (RI) and name if known.
Rank

RT

RI

Name

Predicted Functional
Groups

A. MRSA

1

11.43

1983.451

quinic acid

2

11.18

1930.634

citric acid

3

12.72

2254.577

caffeic acid

4

14.92

2719.366

sucrose

5

16.42

3036.268

kaempferol

16.82

3120.775

quercetin

10.8

1849.648

unknown

6

7
8

3-O16.58

3071.479

caffeoylquinic

18.03

3377.817

raffinose

5.62

754.5775

derivitization
artifact

9

10

Carboxylic Acid,
Alcohol,
Carboxylic Acid Deriv.,
Aromatic
Sec Alcohol,
Carboxylic Acid,
Alcohol,
Carboxylic Acid Deriv.
Hydroxy,
Aromatic,
Carboxylic Acid, Phenol,
Carboxylic Acid Deriv.
None
Carboxylic Acid,
Aromatic
1 2 Diol,
Carboxylic Acid,
Aromatic
Carboxylic Acid,
Carboxylic Acid Deriv.
Carboxylic Acid,
Hydroxy Aromatic,
1 2 Diol,
Phenol Alcohol
1 2 Diol
Sec Alcohol,
Acetal,
Alcohol,
Prim Alcohol
none

B. SA

1

11.18

1930.634

citric acid

2

11.43

1983.451

quinic acid

3

10.67

1821.479

unknown

4

13.78

2479.93

unknown

5

11.85

2071.479

derivitization
artifact

Sec Alcohol,
Carboxylic Acid,
Alcohol,
Carboxylic Acid Deriv.
Carboxylic Acid,
Alcohol,
Carboxylic Acid Deriv.,
Aromatic
Carboxylic Acid,
Carboxylic Acid Deriv.
Carboxylic Acid,
Carboxylic Acid Deriv.,
Aromatic
Carboxylic Acid,
Aromatic
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Table S 7 continued
Rank

RT

RI

Name

10.52

1789.789

unknown

6

7
10.35

1754.577

8

9

unknown
3-O-

16.5

3053.873

10.32

1747.535

10.58

1803.873

1 2 Diol
Sec Alcohol,
Alcohol,
Prim Alcohol,
Carboxylic Acid,
Aromatic,

caffeoylquinic

unknown

10

Predicted Functional
Groups
Carboxylic Acid,
Alcohol,
Carboxylic Acid Deriv

unknown

Carboxylic Acid,
Carboxylic Acid Deriv.
Sec Alcohol,
Alcohol,
1 2 Diol
Prim Alcohol
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CHAPTER IV
METABOLITES ACCUMULATED DURING SALMONELLA ENTERICA
SEROVAR TYPHIMURIUM AND LACTOBACILLUS CASEI YERBA
MATE TREATMENT AND THE RESCUING EFFECT OF EXOGENOUS
IRON SULFATE ON S. TYPHIMURIUM
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This manuscript reports on a learning experience that will remain unpublished.

CS Rempe led this project based on previous work by KP Burris, designed the experiments, and
carried out all experiments aside from the initial Salmonella Typhimurium growth experiments,
which were done by K Higgenbotham and KP Burris. TJ Tschaplinski assisted with the
metabolomics experimental design and analysis. KP Burris and CN Stewart, Jr. assisted with the
development and direction of the project.
Abstract
Plant extracts are a potential source of novel antimicrobials that could kill both pathogenic and
probiotic bacteria. This study assessed the in vitro effect of aqueous yerba mate extract on the
growth of Salmonella enterica serovar Typhimurium and three Lactobacillus strains. S.
Typhimurium was significantly inhibited at 64 mg/ml aqueous yerba mate extract while a
biologically insignificant effect of < 3 log fluctuation in growth was observed in the
Lactobacillus strains. An untargeted metabolomics approach was used to further investigate S.
Typhimurium and L. casei in vitro growth alone or in the presence of yerba mate extract in order
to monitor any decreases in yerba mate phenolic compounds from culture supernatants that could
signify bacterial metabolism. A gas chromatography – mass spectrometry analysis of derivitized
cell culture extracts was used to monitor the accumulation of metabolites in L. casei and in S.
Typhimurium with starting inoculums that were not susceptible to the antibacterial effects of
yerba mate extract. In both S. Typhimurium and L. casei the major metabolites that accumulated
differently between treatments were sugars present in the yerba mate extract and common
constituents of citric acid metabolism. The differences in oxalomalate when S. Typhimurium was
grown with or without yerba mate led to the hypothesis that yerba mate impacts iron
homeostasis, which was tested by supplementing cultures of S. Typhimurium and an inhibitory
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concentration of yerba mate extract with iron sulfate. The partial recovery of S. Typhimurium
with exogenous iron sulfate suggests that disruption of iron, sulfate, or the stability of ironsulfate clusters is involved in the antibacterial activity of yerba mate extract against S.
Typhimurium.
Introduction
Plants produce a complex mixture of biologically active chemicals from which herbal medicines,
modern drugs, antimicrobials, and pesticides have been developed. Phenolic compounds are
abundant in plants and plant-derived food products. When ingested, phenolic compounds are not
readily available to the human system, but they do encounter microbes in the gut that have the
opportunity to metabolize phenolic compounds into derivative molecules (reviewed by de Souza
et al. 2015) that may or may not exert an effect on other microbes or on the human system.
Phenolic plant extracts are known to inhibit a broad range of bacterial enteropathogens (reviewed
by Cowan, 1999), yet they stimulated the growth of Lactobacillus acidophilus (HervertHernández, Pintado, Rotger, & Goñi, 2009) and had no effect on several indigenous gut bacteria
(Lee, Jenner, Low, & Lee, 2006). The ability to target bacterial pathogens and bypass other
bacterial strains could reduce or prevent the rise of diarrhea-causing pathobionts like Clostridium
difficile, which thrive when normal gut-microbe populations are reduced in size and diversity by
antibiotics (briefly reviewed by Cervantes, 2016). A better understanding of microbial
metabolism of phenolic compounds is needed in order to assess health benefits or risks of
consuming certain phenolic sources. Furthermore, a deeper understanding of the mechanisms
behind inhibition or stimulation of phenolic compounds could reveal new means of treating
bacterial pathogens with resistance to common antibiotics.
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Yerba mate is a traditional South American beverage made from aqueous extracts of a plant
known by the same name (Ilex paraguariensis; family Aquifoleaceae). Yerba mate extracts have
antimicrobial activity against a wide range of foodborne bacterial pathogens (Burris et al., 2011,
2012), including the globally relevant enteropathogen, Salmonella enterica serovar
Typhimurium. S. Typhimurium contributes to thousands of infections and about 30 deaths
annually in the U.S. S. Typhimurium strains, including the definitive phage type (DT) 104 strain
2576 used in this study, are also known to be resistant to several antibiotic drugs (CDC, 2013; S.
M. Crim et al., 2014; Scallan et al., 2011). Yerba mate has a high phenolic content and shares
compounds with grape pomace and tea extracts that have been previously observed to stimulate
Lactobacillus acidophilus or leave native gut strains unaffected (Heck & de Mejia, 2007;
Hervert-Hernández et al., 2009; Lee et al., 2006). Lactobacillus strains have also been noted to
metabolize phenolic compounds (Filannino et al., 2015; Rodríguez et al., 2008; SánchezMaldonado et al., 2011). The degradation of aromatic compounds and their breakdown
metabolites were previously observed for several gut bacteria, including Lactobacillus casei and
Salmonella enteridis (Lee et al., 2006). Though S. Typhimurium DT104 has been observed to be
strongly inhibited by phenolic compounds (Lee et al., 2006), it is predicted to contain some
enzymes capable of acting on aromatic compounds, including a salicylate hydroxylase, flavin
reductase, and alcohol dehydrogenase (KEGG database).
While many studies have examined the impact of antimicrobial plant extracts on
probiotics, we have not encountered any metabolomic analyses of S. Typhimurium or L. casei
growth in the presence of yerba mate extract prior to this dissertation. The aims of this study
were to 1) determine the growth effects of different concentrations of yerba mate extract on the
foodborne pathogen S. Typhimurium and 3 Lactobacillus strains and 2) identify any phenolic
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compounds that decreased over time from the supernatants of S. Typhimurium or L. casei during
growth with yerba mate extract. Since no identifiable phenolic compounds were observed to
significantly decrease over time, the limitations of this experimental design were used to improve
the experimental plan for the final chapter of this dissertation. Despite the lack of identifiable
phenolic compounds, oxalomalate was a non-phenolic compound that accumulated when S.
Typhimurium was grown with yerba mate extract. The accumulation of oxalomalate, which is
known to interfere with iron-sulfur clusters of aconitase (Ruffo, Testa, Adinolfi, & Pelizza,
1962), combined with knowledge that phenolics tend to chelate metals, motivated the testing of
iron chelation as a mode of action of yerba mate extract.
Materials and methods
Yerba mate aqueous extraction
A commercial brand of yerba mate tea (Taragui; 100% leaves, Argentina), was purchased from a
local international supermarket (Knoxville, Tenn, USA) and ground with an Oster blender (Boca
Raton, Fl. USA) to a particle size of <1 mm. The ground tea was then extracted in ten times its
mass of water at 4 °C for 3.5 h, 0.45 µm vacuum filtered, frozen at -80 °C, and lyophilized using
a FreeZone, 12 L freeze dryer (Labconco, Kansas City, Mo. USA). Dried extracts were stored at
room temperature in a sealed container until testing.
Phenolic content determination
Phenolic content of the extract was determined using Folin-Ciocalteu’s phenol reagent
(Montreau, 1972). Extracts were resuspended in water (1 mg/ml) and filtered through Whatman
No. 4. The phenolic content was quantified using gallic acid as the standard and expressed in mg
gallic acid equivalents (GAE)/g dry tea extract after the absorbance was read at 765 nm.
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Bacterial culture maintenance
L. bulgaricus ATCC 11842 was purchased from the American Type Culture Collection (ATCC;
Manassas, Va., USA), L. acidophilus (LA-5) and L. casei 431 were generously donated by Chr.
Hansen (Milwaukee, Wi. USA), and S. Typhimurium DT104 strain 2576 was obtained from the
Department of Food Science and Technology at the University of Tennessee. Stock cultures of L.
bulgaricus and S. Typhimurium strains were stored in glycerol at -20 °C. L. casei and L.
acidophilus were received and stored at -80 °C as frozen pellets. Cultures were maintained by reinoculation in ultra-high temperature (UHT) nonfat skim milk (<0.05% fat; Diversified Foods,
Inc., Metairie, LA, USA) or nutrient broth daily and starting new cultures from frozen stocks
weekly. Prior to subculturing and growth experiments UHT milk was centrifuged at 5,000 × g
for 30 min at 4 °C, then sterilely decanted into 50 ml tubes for storage at 4 °C.
Bacterial growth experiments
Yerba mate extracts were reconstituted in MilliQ water and syringe filtered through 0.22 µm
Express PES Membrane (Millipore, Billerica, Ma., USA) prior to microbial susceptibility testing.
All growth experiments were performed in 125 ml flasks containing 12.5 ml UHT milk, 10 ml
reconstituted yerba mate extract or water, and 2.5 ml dilute bacteria ca. 5-6 log CFU/ml or UHT
milk (Lactobacillus strains) or sterile 0.1% peptone (S. Typhimurium) for a total volume of 25
ml. We observed that the Lactobacillus strains grew much faster in milk than in other media, so
all our experiments (including S. Typhimurium experiments) were conducted in milk to optimize
growth time. Experiments were conducted at 37 °C for L. casei, L. bulgaricus, and S.
Typhimurium and at 40 °C for L. acidophilus. Controls were prepared similarly using milk or
water in place of bacteria (negative) or extract (positive) respectively.
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Initial growth experiments performed with S. Typhimurium, L. acidophilus, and L. casei
were all assessed at concentrations of 0, 0.4, 2, 4, 8, 16, 32, and 64 mg/ml yerba mate extract
with time points at 0, 10, 24, and 48 h. L. casei was additionally monitored at 72 h since growth
was slower. L. bulgaricus was monitored only at the concentrations deemed most relevant from
previous experiments (0, 32, and 64 mg/ml for 0, 10, 24, 48, and 72 h). For metabolomics
experiments, starting cultures were diluted to ca. 6-7 log CFU/ml and samples were only taken at
0 h and 48 h in a triplicate experiment with treatments of bacteria + yerba mate extract, only
bacteria, and only yerba mate extract. For iron supplementation experiments, samples were taken
at 0, 10, 24, and 48 h.
At each time point, a sample from each flask was serially diluted in 0.1% sterile peptone
and pour-plated in duplicate using de Man, Rogosa, and Sharpe (MRS) or tryptic soy agar
(TSA). Lactobacillus plates were grown anaerobically using AnaeroGen (Oxoid, Cambridge,
UK) packets in airtight containers at 37 °C for 3 d. S. Typhimurium plates were grown
aerobically at 37 °C for 24 h. Following incubation, colony forming units were enumerated. The
pH was additionally monitored for Lactobacillus strains with 1 ml samples taken at each time
point and measured in duplicate with an UltraBasic UB-10 pH meter (Denver Instruments,
Bohemia, NY., USA).
Metabolomics
A 100 µl sample was taken from each treatment flask at each time point, quenched in 900 µl
80% methanol, vortexed, centrifuged at 20,000 × g for 5 min., and then the supernatant was
collected. This was repeated with the pellet in 900 µl DI water to lyse cells, then in another 900
µl 80% methanol for a final extracted volume of 2700 µl in methanol and water that was stored
at -20 °C in glass tubes. Plastic microcentrifuge tubes were used for initial extraction, so all
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samples should have been equally contaminated with extracted plastic components. 50 µl of
each extract and 10 µl of 0.1000 g/100 ml gallic acid (internal standard) were transferred to
scintillation vials and dried under sterile flowing nitrogen. Each sample was then trimethylsilyl
derivitized with 500 µl acetonitrile and 500 µl MSTFA at 70 °C for 1 hour. After 3 days
(Lactobacillus) or 2 days (S. Typhimurium) an autosampler was used to inject samples into a
GC-MS instrument (Agilent Technologies Inc., Santa Clara, Calif., USA) with a 5975C inert XL
gas chromatograph-mass spectrometer, fitted with an Rtx-5MS with Integra-guard (5%
diphenyl/95% dimethyl polysiloxane) capillary column 30 m by 250 µm by 0.25 µm of film
thickness). This standard quadrupole GC-MS instrument was operated as was detailed in Rempe
and Burris et al. 2015, with electron impact (EI) ionization at 70 eV, six 50 Da to 650 Da scans
per second, and helium gas flow rate of 1.33 ml/min with the injection port in splitless mode.
Temperatures were kept at 250 °C for the injection port, 230 °C for the mass spectrometer
source, and 150 °C for the mass spectrometer quad. The oven was programmed to start at 50 °C
for 2 min, ramp up to 325 °C at 20 °C per min, hold for 11 min, and then cycle back down to 50
°C.
Data analysis
Initial growth experiments were each set up and analyzed as a randomized block design, blocked
on replicate with sampling in duplicate. Treatment design was repeated measures with
concentration applied to each flask and time applied within each flask. Experiments were
replicated three times. Bacterial growth data were analyzed by analysis of variance (ANOVA)
using mixed models (SAS 9.3, SAS Institute, Cary, N.C., USA). Least significant differences
(LSD) were used to compare treatment mean values when significant differences (P<0.05) were
found. Error bars in preliminary growth data represent the standard error of the mean across both
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concentration and time using LSD. Error bars in iron supplemented growth data represent
standard deviations of triplicate experiments.
Metabolomic data was normalized to the gallic acid internal standard, then XCMS
software (C. A. Smith et al., 2006) was used for peak selection and retention time correction with
parameters based on the GC-MS default settings from XCMS Online (Tautenhahn & Patti,
2012).
To investigate treatment and time differences, the unscaled data matrix was analyzed as
a randomized block design, blocked on replicate, with split plots since only two time points (0 h
and 48 h) were sampled within each flask. The three flask treatments were bacteria and yerba
mate extract, bacteria only, and yerba mate extract only. ANOVA assumptions were tested in R
with the Levene test for equal variance (P>0.05) and the Shapiro-Wilks test for normality
(W>0.80). If these assumptions were not met, means were compared with the non-parametric
Kruskal-Wallis test, otherwise data were analyzed using linear mixed models (package nlme, R
Foundation for Statistical Computing, Vienna, Austria). P-values illustrating differences in
treatment means, time point means, and interactions between treatment and time point means
were adjusted for multiple comparisons (false discovery rate 0.05, R function p.adjust) and used
to sort metabolite ions. The Wiley GC-MS library and an in-house library were used to attempt
to identify the compounds containing ions with significant main effects of time and treatment, or
significant main effects of either time or treatment and a significant interaction between time and
treatment (adjusted P<0.05).
Iron assays
Fe2+ and Fe3+ were obtained from iron sulfate heptahydrate and iron chloride, respectively. New,
unused plasticware and autoclaved milliQ water were used for chemical assessments of yerba
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mate iron chelation. Reactions were done in 96-well plates with 250 µl total volumes. Dilutions
of 0.22 µm filtered yerba mate extract were made from a fresh 160 mg/ml stock solution and
FeSO4 solutions were made by diluting a fresh 100 mM stock solution. A 100 mM FeCl3
solution was kept at 4 ⁰C and used for all Fe3+ assays since FeCl3 is stable in solution.
Chlorogenic acid and EDTA were diluted to 1 mM from 100 mM stock solutions and then added
for a final concentration of 0.1 mM. Yerba mate extract was added at final concentrations of 0.32
mg/ml (“high”) and 0.16 mg/ml (“low”) in saturation assays and in competition assays before the
addition of ferrozine. Milk was added at 12 µl milk per ml final volume in saturation assays and
in competition assays (not including volume of ferrozine). Competition assays tested the ability
of ferrozine to compete with the tested chemicals for iron binding. The tested chemicals were
added to the well first (100 µl), then FeSO4 or FeCl3 (25 µl), and then ferrozine (12.5 µl) or
water (12.5 µl; control) was added last. Absorbance was monitored at 562 nm (absorbance peak
of ferrozine-Fe2+ complex) one hour after the addition of ferrozine. Since the binding of
phenolics to iron is visible with UV-vis spectroscopy, saturation assays were done to tentatively
observe where the iron-phenolic complex becomes saturated (100 µl dilute test compound + 25
µl dilute iron solution). No ferrozine was used in these assays and only phenolic chemicals were
tested since others do not have a visible absorbance shift with iron binding. Absorbance at 380
nm, where a slight increase in absorbance was observed with increasing concentrations of iron
(Figure S 2), was recorded after one hour.
Growth assays of S. Typhimurium were supplemented with FeSO4 added at
concentrations of 0, 3.2, and 9.6 mM FeSO4 based on putative saturation regions observed in the
chemical iron binding assessments at 0.1, 1, and 3 mM FeSO4 (Figure S 3). 25 ml total volume
flasks were used with tea in final concentrations of 32 mg/ml or 64 mg/ml and iron in final
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concentrations of 0, 3.2, and 9.6 mM FeSO4. The tea and iron solutions were solvated with pH
5.5 phosphate buffer and adjusted to pH 5.5 before 0.22 µm syringe filtering and subsequent
addition of sterile milk and dilute overnight culture (ca. 5-6 log CFU/ml). Flasks were not acidwashed, so trace amounts of iron likely contributed to experimental error. Data was analyzed to
compare buffered and unbuffered samples without iron in random block design blocked on
replicate with buffer vs. water treatments using repeated measures with time (0, 10, 24, 48 h) and
subsampling. Iron supplemented growth data was analyzed at each time point separately using a
random block design blocked on replicate with iron (0, 3.2, 9.6 mM FeSO4) and tea treatments
(0, 32, 64 mg/ml extract).
Results
Extract and phenolic content
For every 10 g of ground tea, approximately 2.2 g of freeze dried extract was obtained. This
means our initial cold water extract concentration was about 22 mg/ml of the final lyophilized
extract. The lyophilized extract was easily resuspended in water. The highest concentration of
extract (64 mg/ml) in milk had an average starting pH of 5.5, and the phenolic content was
determined to be ca. 81 ± 3.4 mg GAE/g freeze-dried extract.
Bacterial growth with yerba mate extract
Our data demonstrated that a 64 mg/ml aqueous extract of yerba mate was capable of in vitro
inactivation of S. Typhimurium in milk by 48 h (Figure 6A) while minimally affecting the
growth of L. casei, L. acidophilus, and L. bulgaricus (Figure 6B, C, and D, respectively). S.
Typhimurium growth was significantly reduced by ca. > 5 log CFU/ml at 64 mg/ml by 48 h
while we observed fluctuations of < 3 log CFU/ml in the growth of L. casei, L. acidophilus, and
L. bulgaricus relative to their controls (Figure 6).
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Metabolomics
Using adjusted p-values from the ANOVA model, 22 S. Typhimurium metabolites (11
tentatively identified) and 46 L. casei metabolites (16 tentatively identified) were found to be
significantly different across treatment or time. The compounds with significantly different
treatment means, time means, and/or interaction between treatment and time are listed in Table 7
(L. casei) and Table 8 (S. Typhimurium). The identifiable compounds with significantly altered
accumulation patterns between treatment and/or time groups tended to be either sugars consumed
from the yerba mate extract or compounds involved in common metabolic pathways, including
the citric acid cycle. The only putatively identified phenolic compound was sinapyl alcohol in
the L. casei supernatant, but it accumulated in the bacteria treatments both with and without
yerba mate extract.
Iron binding assays
Using ferrozine to monitor Fe2+, the expected linear relationship was observed between 562 nm
absorbance (ferrozine-Fe2+ complex) and the concentration of added FeSO4 in water. This linear
relationship was clearly seen with water, chlorogenic acid, and tea samples, indicating they did
not effectively compete with ferrozine to bind Fe2+ (Figure 7A). The EDTA control and all the
samples containing milk showed a delayed absorbance as EDTA or milk bound to Fe2+ and
removed it from ferrozine (Figure 7A). At about 0.5 mM FeSO4, though, there was sufficient
iron to interact with ferrozine and a linear relationship between absorbance (Fe2+ complex
formation) and iron concentration was observed from that point (Figure 7A).
There was no signal with added FeCl3 in water, with EDTA, or with milk, as expected
since FeCl3 supplies Fe3+ which cannot interact with ferrozine (Figure 7C). Chlorogenic acid and
all the samples containing tea did show a delayed absorbance though, indicating that they are
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capable of converting Fe3+ to Fe2+ (Figure 7C). Controls without ferrozine showed no observable
interference at 562 nm (Figure 7A, Figure 7D).
In saturation assays the native absorbance was monitored at 380 nm, a wavelength where
absorbance was observed to vary between yerba mate extracts with high and low iron
concentrations (Figure S 2). The tea and milk trends showed very little difference with both
FeCl3 and FeSO4. When tea and milk were combined in growth assay proportions, a clear curve
was visible with the absorbance signal showing theorized iron saturation at about 1-1.5 mM Fe
(Figure S 3).
Bacterial growth with iron supplementation
S. Typhimurium with 32 mg/ml tea extract grew at all concentrations of added iron with no
significant difference at 48 h. With 64 mg/ml, S. Typhimurium was killed by 48 h in the
treatments with 0 mM FeSO4 (differed from all other treatments with P<0.05), but survived with
a mean of 7.5 log CFU/ml when supplemented with 9.6 mM FeSO4, which was not significantly
different from the ca. 8.5 log CFU/ml means of the 0 and 32 mg/ml tea treatments with and
without iron at 48 h (Figure 8). The treatment with 64 mg/ml tea and 3.2 mM iron grew with a
mean of ca. 4.5 log CFU/ml at 48 h, which was significantly different from all the other
treatments at 48 h (P < 0.05).
Discussion
A 64 mg/ml concentration of the aqueous extract of yerba mate significantly inhibited the growth
of S. Typhimurium but did not have a major effect on the growth of L. casei, L. acidophilus, or
L. bulgaricus in vitro. Although 64 mg/ml is higher than the 14.6 mg/ml previously observed to
inhibit S. Typhimurium in tryptic soy broth (TSB) (Gonzalez-gil et al., 2014), growth in milk
rather than TSB has been observed to reduce S. Typhimurium susceptibility to antibiotics
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(Branen & Davidson, 2004). 64 mg/ml is also greater than the original cold water extract we
obtained, which was 22 mg/ml. 22 mg/ml might be comparable to a commonly ingested
concentration of yerba mate since a range of 21.7-34.5 mg/ml was obtained from aqueous yerba
mate leaf extracts in another study (Sambiassi, Escalada, & Schmalko, 2002), or higher than an
ingested concentration since the “soluble solids” obtained from yet another set of hot and cold
water extractions ranged from 4.8-7.8 mg/ml (Bastos, Fornari, De Queiroz, Soares, & Torres,
2005).
Yerba mate extract is rich in phenolic compounds (Heck & de Mejia, 2007); this
evaluation found ca. 81 ± 3.4 mg GAE/g dry extract, comparable to the 110.5 ± 14.3 mg GAE/g
observed previously (Deladino et al., 2013). Since phenolics are known to have antibacterial
properties, GC-MS with TMS-derivitized samples was used to profile any changes in phenolic
compounds and common bacterial metabolites.
The first goal of this metabolomics analysis was to assess whether any phenolic
compounds present in the tea extract were metabolized by the bacteria. Although the changes in
L. casei growth patterns were not biologically meaningful, they were statistically significant
(P<0.05) and showed a growth lag between 10 h and 24 h in comparison to controls. This trend
could be explained by a particular compound in the extract initially inhibiting growth, but then
later being degraded or utilized by L. casei. However, we did not observe any identifiable
phenolic compounds with a significant change between 0 h and 48 h except for sinapyl alcohol,
which appeared to be produced by L. casei or be a breakdown product of milk components.
Either way, the changes in this compound putatively identified as sinapyl alcohol were
independent of yerba mate extract. Most of the compounds observed to decrease over time in the
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tea samples were sugars with both L. casei and S. Typhimurium, which were likely metabolized
as carbon sources.
Since there were no identifiable phenolic compounds with significant changes across
time and yerba mate treatment, the S. Typhimurium pathways altered by yerba mate extract were
further investigated in literature searching in order to create hypotheses about yerba mate’s
antibacterial mechanism(s). The metabolomics analysis revealed a significant difference in
oxalomalate between S. Typhimurium treatments, so it was investigated further and found to
compete with iron-sulfur clusters for binding to eukaryotic aconitase, which is structurally very
similar to aconitase A of Salmonella, and to bacterial isocitrate lyase (Baothman, Rolfe, &
Green, 2013; Walden, Selezneva, & Dupuy, 2006). Oxalomalate is often formed nonenzymatically by the interaction of oxaloacetate and glyoxylate. It is not clear whether the
oxalomalate observed was produced non-enzymatically or enzymatically by the bacteria.
Since phenolic components of yerba mate extract are already known to have a strong
ability to chelate metal ions, including iron (Guo et al., 2007; Kono & Kashine, 1998), we
decided to test the hypothesis that the yerba mate extract chelates iron and so starves S.
Typhimurium of this necessary element. This hypothesis was also in accord with our observation
that 3 Lactobacillus strains are generally unaffected by yerba mate extract since Lactobacilli use
manganese rather than iron and they lower the pH of their environment to levels that generally
deter the chelation of any metal ions (Imbert & Blondeau, 1998). However, metabolic signs of
iron stress through increased amounts of enterobactin and pyruvic acid (Reissbrodt et al., 1997),
were not apparent since neither of these compounds were identifiable in the GC-MS spectra.
In order to probe the relationship of iron to our antibacterial tea system, the iron binding
capabilities of yerba mate extract were assayed, followed by EDTA, chlorogenic acid, milk, and
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combinations of tea and milk (Figure 7). It is clear that the milk alone and the milk and tea
combination are capable of binding Fe2+ from the ferrozine competition assay, which we
expected since milk contains the iron storage protein lactoferrin. However, the ferrozine assay
did not show any binding capabilities of chlorogenic acid or yerba mate extract. Chlorogenic
acid has been previously observed to chelate iron in 1:1 and 3:1 ratios, with visible UV-vis
absorbance shifts at 324 nm and 355 nm (Kono & Kashine, 1998). Yerba mate was observed to
have shifts at 320 nm and 380 nm that could be representative of single phenolics depleting and
an iron-phenolic complex forming (Figure S 2). With this observation and claims of yerba mate
iron chelation in the literature (Huang et al., 2014; Salkić & Ćavar Zeljković, 2014), it is possible
that ferrozine is able to bind more strongly to Fe2+ than either chlorogenic acid or any of the
yerba mate phenolics. By further monitoring the native absorbance shift of both the tea and
chlorogenic acid at 380 nm, saturation curves were observed that could be interpreted as the
formation of an iron-phenolic complex (Figure S 3). Using the proportions of iron to tea found
where the saturation curve plateaued, we selected two iron concentrations that might provide
enough uncomplexed iron for the bacteria to survive low iron stress. These concentrations were
close to the start of the plateau since bacteria generally require only 10-7 to 10-5 M iron for
optimal growth (Andrews, Robinson, & Rodríguez-Quiñones, 2003).
The supplementation of FeSO4 at 9.6 mM clearly rescued S. Typhimurium from the
antibiotic effects of 64 mg/ml yerba mate extract, although growth was still significantly below
the level of the treatments with no tea and the 32 mg/ml tea. This supports the hypothesis that the
iron chelation of yerba mate extract plays a major role in its antibacterial function. Although
many other studies hypothesize iron as a potential factor in the antimicrobial activity of phenolic
plant extracts, to our knowledge we are the first to test it with a whole plant extract. A similar
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assay with tannic acid found that exogenous iron prompted the recovery of bacterial pathogens
(Chung et al., 1998). A possibility remains that milk components acted synergistically with
phenolics to withhold iron since direct evidence of yerba mate binding to iron was not observed.
Future experiments are needed to assess whether a major portion of yerba mate extract’s
antibacterial activity against S. Typhimurium is simply from chelating iron or if a more complex
mechanism is at work.
Conclusion
The effects of yerba mate extract on the growth of three Lactobacillus strains and the pathogen S.
Typhimurium was evaluated, the metabolic effects of yerba mate extract on L. casei and S.
Typhimurium was surveyed, and finally the hypothesis that iron is involved in the antibacterial
effect of yerba mate extract against S. Typhimurium was tested. It was found that the addition of
ferrous iron sulfate rescued S. Typhimurium from the antibacterial effect of yerba mate extract.
Additional experiments are needed to assess whether it was chelation of iron by yerba mate or a
different mechanism that is the main source of the antibacterial effect, but this study has verified
that iron has an influence.
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Appendix
Figures

Figure 6. Growth trends (log CFU/ml) of A. S. Typhimurium, B. L. acidophilus, C. L. casei, and
D. L. bulgaricus in UHT skim milk at different concentrations of yerba mate extract. Error bars
represent ± 1 standard deviation (triplicate experiment).
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Figure 7. Plots show competition assays of ferrozine; A. Fe2+ (FeSO4) and C. Fe3+ (FeCl3) were
tested and controls without ferrozine were also tested with B. Fe2+ and D. Fe3+. Experiments
were done at least in duplicate. Error bars represent standard deviation. Tea concentrations were
0.32 mg/ml (“high”) and 0.16 mg/ml (“low).
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Figure 8. Growth of S. Typhimurium in 3 concentrations of iron (FeSO4) and 2 concentrations of yerba mate extract (“tea”) is plotted
over time. Error bars show standard deviation for 3 replicates with the exception of the 10 h time point, which only had 2 replicates.
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Tables
Table 7. L. casei metabolites found to be significantly different between treatments with
‘control_no_bacteria’ = milk+tea, ‘control_no_tea’ = milk+bacteria, and ‘tea’ =
milk+tea+bacteria. Extracted ion intensity values normalized to a gallic acid internal standard are
listed with data ranges in parentheses. (attached)
Table 8. S. Typhimurium metabolites found to be significantly different between treatments with
‘control_no_bacteria= milk+tea, ‘control_no_tea ’ = milk+bacteria, and ‘tea’ =
milk+tea+bacteria. Extracted ion intensity values normalized to a gallic acid internal standard are
listed with data ranges in parentheses. (attached)
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Supporting information
Supporting figures

Figure S 2. Ultraviolet-visible spectra of yerba mate extract (0.16 mg/ml tea; “low”
concentration) with FeSO4 or FeCl3 at varying concentrations. Points are the means of technical
duplicates; one representative biological replicate is shown. Arrows indicate the tendency of
absorbance to shift up or down corresponding with increasing or decreasing iron concentrations.
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Figure S 3. Saturation assays are plotted for A. Fe2+ (FeSO4) and B. Fe3+ (FeCl3); absorbance
was monitored at 380 nm. No ferrozine was added for this assay. Experiments were done at least
in duplicate; error bars represent standard deviation. Tea concentrations were 0.32 mg/ml
(“high”) and 0.16 mg/ml (“low).
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CHAPTER V
METABOLIC ANALYSIS OF THE MECHANISMS OF ACTION OF
YERBA MATE EXTRACT ON SALMONELLA ENTERICA SEROVAR
TYPHIMURIUM
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Abstract
Salmonella enterica serovar Typhimurium is a Gram-negative enteropathogen that infects
millions of people worldwide each year; the rapid emergence of antibiotic resistant strains has
heightened the urgency to develop effective treatments for this pathogen. Aqueous extracts of
yerba mate (Ilex paraguariensis) provide effective therapy, in vitro, for the drug-resistant S.
Typhimurium DT104. Unfortunately, while some of the chemical constituents that contribute to
the extract’s antibacterial activity have been identified, the mechanism of action of the extract is
still unknown and of crucial importance to its future potential in combating antibiotic resistant
bacteria. Yerba mate extract induced changes in central carbon metabolism in S. Typhimurium,
reduced catalase activity by means other than direct inhibition, and did not change membrane
integrity (except at the initial 0 time point, where differences were not resolved) despite a
significant increase in the production of a cell wall precursor. Additional significant differences
were observed in the global metabolic regulators alpha-ketoglutarate and acetylphosphate, the
energy-related molecule NAD+, and in an unexpected match to the antibacterial compound
yohimbine. This work provides the first evaluation of the mechanism of action of yerba mate
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extract on S. Typhimurium, revealing a major impact on central carbon metabolism, catalase
activity, and possible metabolic links to interference in energy production and membrane
integrity. The putative identification of the antibacterial compound yohimbine and the many
unidentified compounds provides additional avenues for future investigations of novel yerba
mate compounds capable of traversing or binding to S. Typhimurium’s membrane.
Introduction
Nontyphoidal Salmonella species are widespread food-borne enteropathogens responsible for
more than one million infections annually in the United States alone (S. Crim et al., 2015;
Scallan et al., 2011). The cost of these infections places a significant burden on the U.S.
healthcare system, leading to over 2,000 hospitalizations and 30 deaths per year (S. Crim et al.,
2015; Scallan et al., 2011). Perhaps of even greater concern, Salmonella enterica serotype
Typhimurium accounts for approximately 12% of serotyped Salmonella infections in the U.S. (S.
Crim et al., 2015), and strains have emerged that are reported to be resistant to the most common
antimicrobial agents (CDC, 2015). The emergence of drug resistance in this globally relevant
pathogen highlights the need to identify new antibacterial agents, and serves as the motivation
for this work.
One source of novel antibacterial agents is plants, which have evolved to produce
numerous biologically active chemicals. At present, antibacterial agents derived from plants are
not a major source for pharmaceutical-grade antibiotics, likely due to the generally higher
minimum inhibitory concentrations compared to bacterial-derived antibiotics (discussed by
Tegos & Stermitz, 2002), concerns over quality control (Yau, Goh, & Koh, 2015), and
difficulties in obtaining intellectual property for natural products (Silins, Tan, & Chan, 2015).
Despite these concerns, plants contain many weakly antibiotic compounds that may act
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synergistically to increase the efficacy of other antibiotics (Lewis & Ausubel, 2006). One
example of synergism in plant antibiotics are the barberry plants (Berberis), which produce the
antibiotic berberine that is only effective in the presence of a multidrug resistance pump
inhibitor, like the phytochemical 5’-methoxyhydnocarpin (Tegos & Stermitz, 2002). This
synergistic mechanism of action shows a level of complexity not readily observed in synthetic
pharmaceutical systems. In addition to synergistic mechanisms, single plant antibacterial
compounds, such as eugenol (Devi, Nisha, Sakthivel, & Pandian, 2010), ferulic acid (Borges et
al., 2013), and essential oils (Bakkali et al. 2008), have been shown to be involved in membrane
disruption, production of reactive oxygen species (ROS), and inhibition of transcription,
translation, and DNA replication (Abreu et al., 2012; Cowan, 1999; Radulović, Blagojević,
Stojanović-Radić, & Stojanović, 2013; Upadhyay, Upadhyaya, Kollanoor-Johny, &
Venkitanarayanan, 2014). In plant antibacterial compounds, the ability to disrupt the bacterial
membrane/cell wall, as assayed by monitoring efflux of intracellular components, influx of
hydrophobic dyes or antibiotics, or microscopic observation, has been frequently attributed to
polyphenolics (Borges et al., 2015; Cushnie & Lamb, 2011; Devi et al., 2010; Di Pasqua et al.,
2007; Gill & Holley, 2006; Helander et al., 1998; Lambert, Skandamis, Coote, & Nychas, 2001;
Nohynek et al., 2006; Tyagi, Singh, Kumari, Kumari, & Mukhopadhyay, 2015). Similarly, plant
polyphenols have been implicated in the formation of ROS in bacteria, based on colorimetric or
fluorescent dyes (Dwyer, Collins, & Walker, 2015; Nakamura et al., 2015; Zhao, Hong, &
Drlica, 2014). Inhibition of proteins, such as FtsZ (Hwang & Lim, 2015) and DNA gyrase
(Plaper et al., 2003), or direct binding to DNA (Lou et al., 2012; Plaper et al., 2003) by plant
extracts have been less studied, but have been shown to be important to the generation of
antibacterial activity in some systems. As bacteria continue to develop resistance to current
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pharmaceuticals, alternative compounds will be necessary to quell this threat, with plants
providing a vast resource of novel compounds with various modes of action.
The goal of this study was to examine the mechanism of action of an aqueous extract of
yerba mate, a leaf tea made from Ilex paraguariensis, on Salmonella Typhimurium. Previous
studies have demonstrated the antibacterial activity of yerba mate against a wide range of
foodborne bacterial pathogens (Burris et al., 2011, 2012, 2015; Hongpattarakere, 2000; Kubo &
Muroi, 1993; Martin et al., 2013; Sari, Turkmen, Polat, & Velioglu, 2007; Tsai, Tsai, Chien, Lee,
& Tsai, 2008). Yerba mate is known to contain numerous antibacterial phenolic compounds,
including chlorogenic acids, quercetin, and ferulic acids (Heck & De Mejia, 2007). While pure
phenolic compounds isolated from yerba mate have been investigated for their antibacterial
modes of action (Martin et al., 2013), no studies have examined the antibacterial mechanism of
the whole extract. In this work, membrane disruption, catalase activity, and the metabolomic
profiles of Salmonella Typhimurum DT104 in response to a sub-lethal concentration of yerba
mate extract was examined.
Results
At a starting S. Typhimurium concentration of ca. 6 log colony forming units (CFU)/ml, the
minimum inhibitory concentration (MIC) of yerba mate was found to be 10 mg/ml based on
killing at 24 hours (h) (Figure 9A). At concentrations < 2.5 mg/ml, a lag in growth was observed
over the first 4 h of culture, with the cultures fully recovering by 8 h. This lag was more
pronounced at 5 mg/ml with the cultures failing to reach the culture maximum over the 24 h
period of the experiments. When the starting concentration of S. Typhimurium was increased to
ca. 9 log in order to obtain sufficient cell quantities for subsequent assays, a MIC was not
observed over the tested concentration range; however, at a dose of 80 mg/ml yerba mate, there
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was a significant reduction in growth after 2 h, thus this dose was termed the sub-lethal dose
(Figure 9B). For simplicity, the three S. Typhimurium treatment conditions with ca. 9 log
CFU/ml starting culture conditions will be referred to as controlno tea (0 mg/ml yerba mate extract
with S. Typhimurium), tea (80 mg/ml yerba mate extract with S. Typhimurium), and controlno
bacteria (80

mg/ml yerba mate extract with phosphate buffered saline (PBS) pH 7.4 instead of S.

Typhimurium) throughout the remainder of this paper.
No significant differences between controlno tea and tea treatments were observed in
measurements of optical density at 600 nm (OD600), so the crystal violet assay was not adjusted
to OD600 (Figure S 4). The crystal violet assay for membrane integrity showed no significant
differences between controlno bacteria compared to tea except at the initial timepoint (Figure 10B),
so the significant differences that were observed between controlno tea and tea can generally be
explained by the interaction of yerba mate extract with crystal violet. Thus, no change in
membrane integrity was detected with this assay except for a possible unresolved loss of
membrane integrity immediately after the tea treatment was applied. Catalase activity, however,
was observed to be reduced in the tea treatment as compared to the controlno tea treatment. No
effect of controlno bacteria was observed on catalase (Figure 10A).
The intracellular metabolomics analysis showed that 20 to 34 identifiable metabolites
were significantly different in each of the six displayed treatment comparisons (tea vs. controlno
tea at

0, 40, and 240 min and tea vs. controlno bacteria at 0, 40, and 240 min) that focus on

differences between the tea treatment and control treatments at each time point (Table 9, Table
10, Table 11, Table 12, Table 13, Table 14). The tricarboxylic acid (TCA) cycle (Figure 11) was
the pathway most enriched by the identifiable compounds in Tables 9-14.
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The pentose phosphate pathway (PPP) (Figure S 5), glycolysis pathways (Figure 12), and
amino acid and nucleotide biosynthesis/metabolism (Figure S 6, Figure S 7) were also
represented in the identifiable compounds with significant differences between tea and control
treatments. Two identifiable compounds with significant differences between tea and controls,
yohimbine and ornithine, were observed to be present only in tea and not in controlno tea (Figure
13, Figure S 7). As seen in the plots of succinate/methylmalonate, fumarate, and malate, some
common metabolic products are also clearly present in the tea treatment (Figure 11). In a brief
summary of treatment differences, there were 7 compounds with significant differences between
tea and both controls at 0 min, 15 compounds at 40 min, and 10 compounds at 240 min (Tables
9-14). Among these compounds, aconitate, citraconate, citrate/isocitrate, flavin mononucleotide
(FMN), fumarate, and N-carbamoyl-L-aspartate were significantly different between tea and
both control treatments at 0 min and at 40 min Acetylphosphate, alpha-ketoglutarate,
sedoheptulose 1/7-phosphate, and valine were significantly different between tea and both
controls at 40 min and at 240 min; there were no compounds significantly different between tea
and both controls across all three time points (Tables 9-14).
Discussion
The MIC of yerba mate was 10 mg/ml with ca. 6 log CFU/ml starting culture based on killing at
24 h (Figure 9A). This was similar to the 7.4 mg/ml MIC previously observed (Gonzalez-gil et
al., 2014) with aqueous yerba mate extract and S. Typhimurium DT104. An MIC of 10 mg/ml is
much higher than the µg/ml-level MICs of antibiotics currently in use, but is comparable to the
S. Typhimurium MICs of other plant extracts, which were observed to range from 0.78 to 6.25
mg/ml (Marasini et al., 2015). Variation between manufacturers’ batches (Golozar et al., 2012)
would be expected to contribute to differences in MIC between studies. There is a known
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“inoculum effect” such that antibiotic susceptibility is reduced when the bacterial inoculum
concentration is increased. This was observed when the S. Typhimurium inoculum concentration
was increased to ca. 9 log CFU/ml in order to obtain enough biomass for assays in the current
study (Figure 9B). The inoculum effect was previously observed with multiple antibiotic classes,
including aminoglycosides, beta-lactams, and fluoroquinolones in studies that focused on
Escherichia coli and Staphylococcus aureus (Greulich, Scott, Evans, & Allen, 2015; Udekwu,
Parrish, Ankomah, Baquero, & Levin, 2009; zur Wiesch et al., 2015). S. Typhimurium inoculum
effects have been characterized with beta-lactams (Eng, Cherubin, Smith, & Buccini, 1985) but
recent work with inoculum effects has primarily focused on E. coli and S. aureus.
Yerba mate contains a diverse mixture of compounds, including polyphenolics,
xanthines, alkaloids, and flavonoids, that likely contribute to its antioxidant, stimulant,
antibacterial, and other bioactive properties (reviewed by Heck & De Mejia, 2007). The
antibacterial mechanisms of many specific plant constituents such as eugenol or ferulic acid have
been studied with assays for membrane integrity, reactive oxygen species, and binding to key
proteins (Borges et al., 2013; Devi et al., 2010). Membrane integrity is traditionally assayed by
monitoring efflux of intracellular components, influx of hydrophobic dyes or antibiotics, or
microscopic observation and has generally been found to contribute to the antibacterial
mechanism of polyphenolics (Borges et al., 2015; Cushnie & Lamb, 2011; Devi et al., 2010; Di
Pasqua et al., 2007; Gill & Holley, 2006; Helander et al., 1998; Lambert et al., 2001; Nohynek et
al., 2006; Tyagi et al., 2015), although quercetin has been observed to increase cell wall rigidity
(T. Wu, He, et al., 2013). The crystal violet membrane integrity assay used in the current study
revealed that the major differences between tea and controlno tea treatments could be explained by
a precipitate of the tea interacting with crystal violet dye, as evidenced by the controlno bacteria
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treatment (Figure 10B). The only significant difference between tea and controlno bacteria occurred
at the initial 0 min time point (Figure 10B), which suggests that there could be a slight,
immediate change in membrane integrity upon addition of the tea treatment (the tea treatment
took up more crystal violet than the controlno tea or controlno bacteria treatments) that occurred too
quickly for this experiment to resolve.
ROS assays based on colorimetric or fluorescent dyes are also common and generally conclude
that phenolics promote ROS formation (Dwyer et al., 2015; Nakamura et al., 2015; Zhao et al.,
2014). The current work hypothesized that yerba mate extract would follow a noted trend of
increased ROS with antibacterial activity (Kohanski, Dwyer, Hayete, Lawrence, & Collins,
2007), which would in turn upregulate the expression of catalase. Catalase activity of bacterial
cells, however, was determined to be significantly reduced with the tea treatment compared to
the controlno tea treatment at 0 h, 4 h, and 8 h (Figure 10A). Again, the difference at 0 h suggests
fluctuation on a time scale smaller than this experiment was able to accurately measure. The
consistently reduced catalase activity of S. Typhimurium in the tea treatment was not due to the
direct inhibition of catalase by the tea extract (Table S 9), but could be a result of transcriptional,
translational, or post-translational control of tea components. Since yerba mate extract is well
known for its high antioxidant activity (Filip, Lotito, Ferraro, & Fraga, 2000; Valerga, Reta, &
Lanari, 2012; Valerga, Shorthose, & Lanari, 2013), it is also possible that ROS species were
reduced by the tea, thus triggering a downregulation of catalase by S. Typhiumurium.
Additional phenolic mechanisms of action of that were not tested in this work include
binding to specific proteins like FtsZ (Hwang & Lim, 2015) and DNA gyrase (Plaper et al.,
2003) or direct binding to DNA (Lou et al., 2012; Plaper et al., 2003). Complex plant extracts,
including berries (reviewed by Puupponen-Pimiä et al. 2005) and essential oils (reviewed by
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Bakkali et al. 2008) have been evaluated for mechanisms of action, especially membrane
integrity, ROS production, and protein binding. Three edible medicinal plants (Yong, Ooh, Ong,
Chai, & Wong, 2015) were recently evaluated for their mechanisms of action using proteomic
analyses of bacterial pathogens, but to our knowledge, the current study was the first to survey
the metabolome of pathogenic bacteria in order to gain an understanding of a plant extract’s
antibacterial mechanism(s). Bacterial metabolomics has been shown to be capable of
differentiating classes of common pharmaceutical antibiotics (Belenky, Ye, Porter, Schwarz, et
al., 2015; Dörries, Schlueter, & Lalk, 2014) and evaluating pure phytochemicals (Mousavi,
Bojko, Bessonneau, & Pawliszyn, 2016) but has not previously been applied to plant extracts.
The metabolomics assessment of S. Typhimurium (Table 9-14, Figures 11, 12, S 5-S7) must be
interpreted carefully since the “intracellular” metabolites of cells collected on filters were
evaluated, meaning that the controlno bacteria sample consisted of tea components that adhered to
the filter rather than all possible components in the tea. Thus, metabolites that are absent from
controlno bacteria may still be present in the tea extract; metabolites that are present in the controlno
bacteria treatment

were definitely present in the tea extract, but not necessarily at the same

concentration observed. Thus, the tea and control treatments have the potential to contain an
intracellular metabolite, a metabolite bound extracellularly, and metabolites adhered to the filter.
The metabolomics results are additionally limited by which metabolites are identifiable and the
possibility that mechanisms of action may either non-specifically alter the metabolome or not
impact the metabolome at all (as observed in Vincent, Ehmann, Mills, Perros, & Barrett, 2016).
Based on the results from the metabolomics data, there are three categories that the significantly
different metabolites could fall under: 1) influx from the tea extract, 2) general stress conditions,
and/or 3) antibiotic specific stressors.
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Influx from tea extract
A significantly larger mean in tea vs. controlno tea followed by a decrease over time in the tea
treatment, as in citrate/isocitrate and aconitate of the tricarboxylic acid (TCA) cycle (Table 9-11,
Figure 11), is a common trend that may signify an immediate cellular response, but may also be
due to the influx of that metabolite into the cell from the tea extract. Yohimbine in particular can
be confidently explained by influx from the tea since it is not known to be produced by S.
Typhimurium and is absent from the controlno tea treatment. Succinate, fumarate, and malate may
also be transported into the cell from the tea extract and either join in the TCA cycle or, more
likely, inhibit the progression of the TCA cycle since most TCA cycle products act as inhibitors
through feedback regulation.
General stress conditions
Lag and exponential growth phases differ, with lag phase showing slow growth and increased
expression of metal uptake and oxidative stress systems (Rolfe et al., 2012), but this should not
impact the results of the current study since both controlno tea and tea are in lag phase at 40 min
and late exponential phase at 4 h. Osmolarity, however, was expected to be a factor in the
response of S. Typhimurium to the tea treatment, but common osmoprotectants like glutamate
and proline (discussed by Frossard et al., 2012) were observed to have no significant differences
between treatments, and other osmoprotectants were not identified. Additionally, oxidative stress
effects were expected, but not observed in the metabolomics data. For example, glutathione to
glutathione disulfide ratios, associated with oxidative stress conditions (reviewed by Pompella,
Visvikis, Paolicchi, De Tata, & Casini, 2003), had no significant differences compared to the
controls, and glutathione disulfide was not observed. Other key indicators of oxidative stress,
like 8-oxo-guanine (reviewed by Farr & Kogoma, 1991), were not present in the library of
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standards used for compound identification, thus it was not possible to analyze their levels. One
generic stress response is the downregulation of genes needed for cell growth, but specific
stressors tend to give specific responses, especially with metabolomics data (Jozefczuk et al.,
2010). In general, the later stages of the TCA cycle (succinate/methylmalonate, malate,
fumarate) were the only cell growth-related steps that appeared to be static. Without flux
information, the static appearance of these compounds could be due to constant movement as
they are converted to the next metabolite, or it could be due to no movement at that portion of the
TCA cycle. There are few entirely generic metabolic stress responses, but downregulation of the
latter portion of the TCA cycle is one that might be at work in the current study.
Antibiotic specific stressors
Stress-specific trends in antibiotic-treated bacteria have previously been used to identify
mechanisms of the antibiotic (Belenky, Ye, Porter, Schwarz, et al., 2015; Dörries et al., 2014;
Vincent et al., 2016). In E. coli treated with norfloxacin, kanamycin, or ampicillin, no key
distinguishing features were visible at 30 min, but large increases in levels of citrate, succinate,
and oxidized nicotinamide adenine dinucleotide (NAD+ ) and decreases in nucleotide precursors
(including ribose 5-phosphate) were observed for all the tested antibiotics (Belenky, Ye, Porter,
Schwarz, et al., 2015). The current study did not observe any of these trends at 40 min. Similarly,
trends in nucleotides, cell wall precursors, and other metabolites that were previously seen to
define a thymidine kinase inhibitor and a 1-deoxy D-xylulose 5-phosphate (DXR) pathway
inhibitor (Vincent et al., 2016) were not observed in the significantly different metabolites of the
current work.
UDP-N-acetylglucosamine is a lipid precursor that normally favors conversion to acylACP; however, in the presence of an inhibitor of LpxC, the enzyme at the following step of lipid
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A synthesis, acyl-ACP accumulates and may push the reverse reaction to convert it back to UDPN-acetylglucosamine (Barb & Zhou, 2008; reviewed by Mcclerren et al., 2005). In the current
work, UDP-N-acetylglucosamine was significantly higher in the tea treatment at 40 min but not
different at 240 min, so it is possible that lipid A synthesis was blocked, causing acyl-ACP (not
in library of standards) accumulation and pushing a reverse reaction to UDP-Nacetylglucosamine, which might have transiently risen at 40 min before being shuttled to other
pathways. Membrane integrity effects would be expected if lipid A synthesis was blocked, so
concentrations of the inhibitor may have been too low relative to cell concentrations to have a
visible membrane effect under the tested conditions. The difference in membrane integrity seen
at 0 min supports an immediate membrane effect that is quickly overcome due to the large
number of bacterial cells, but a faster membrane integrity assay is needed to resolve the time
scale of any membrane effects and ensure equivalent starting conditions.
Significant differences in amino acids and nucleotides between controlno tea and tea were
only observed with valine (decreased in tea at 240 min) and cytidine monophosphate (increased
in tea at 240 min), suggesting interference or specific regulation of enzymes unique to valine and
CMP synthesis or metabolism. However, no enzymes were noted to be unique to valine or CMP
synthesis based on KEGG pathways (Kanehisa & Goto, 2000). CMP might also increase due to
higher levels of RNA degradation, but other nucleotides would be expected to increase if this
were the case. UMP, AMP, GMP, and IMP had noisy spectral abundance data that might show
significant trends with additional replication.
Respiration occurs in the plasma membrane of Salmonella species, and uses the
membrane-bound NADH complex, succinate dehydrogenase, and lactate dehydrogenase to
gather electrons. Electrons are then passed to ubiquinone or another electron acceptor, powering
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proton pumps that create the gradient needed for ATP synthase to function. NADH use by the
NADH complex is the most efficient electron source since it is furthest from the final electron
acceptor, capable of generating 3 ATP compared to 2 from succinate dehydrogenase. Flavin
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are also important in electron
transfer and frequently serve as cofactors in biosynthesis functions. The NADH complex
contains a FMN cofactor and the succinate dehydrogenase complex holds an FAD cofactor. FAD
levels were not different between tea and controlno tea, and the slightly elevated FMN levels at 0
and 40 min could be explained by immediate influx from the tea extract. NAD+, however, had a
significant increase of 0.7 fold at 240 min, which, although a small fold-change, amounts to a 5
log difference in abundance based on spectral intensity units (Table 11, Figure 13). NADH was
not visible in these data and so it is presumed to have been used immediately after being
produced. The higher levels of NAD+ observed in tea vs. controlno tea might signify slowed
NADH production. Most NADH is produced in glycolysis, the pentose phosphate pathway
(PPP), and the TCA cycle, the pathways in which the most differences in metabolites between
treatments were observed. All TCA cycle enzymes with the exception of isocitrate
dehydrogenase are known to be downregulated during lag phase, which is associated with ROS
stress (Rolfe et al., 2012). The TCA enzymes following isocitrate dehydrogenase, which
produces alpha-ketoglutarate, have no significant changes and thus could be down-regulated by
the stress of yerba mate extract. This would leave the TCA cycle to produce only a single NADH
from isocitrate dehydrogenase. Glycolysis showed no significant differences in pyruvate or
acetyl CoA, the substrate and product for the NADH formation step. In the PPP 6phosphogluconate, the precursor to an NADH reaction, is elevated at 0 and 240 min, which
might be expected to increase NADH production. Based on these results, a reduced TCA cycle
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would have the greatest impact on NADH production, but flux data would be needed to test
whether the TCA cycle has been truncated or has constant flux under the tea treatment
conditions.
Additional significantly different metabolites of particular interest are alphaketoglutarate, phosphoenolpyruvate (PEP), and acetylphosphate. Alpha-ketoglutarate has an
unusual trend in which it is significantly greater than the controlno tea treatment at both 40 min
(2.1 fold higher) and 240 min (1.3 fold higher). As a key regulator and signaling molecule for
both carbon and nitrogen metabolism, alpha-ketoglutarate alterations can be very influential.
Alpha-ketoglutarate inhibits glucose transporters (Doucette, Schwab, Wingreen, & Rabinowitz,
2011), PEP synthetase (Chulavatnatol & Atkinson, 1973), and citrate synthase (Pereira, Donald,
Hosfields, & Harry, 1994), so it may be responsible for the decrease in citrate over time after an
initial high production rate or influx from the tea. Citrate could also be decreasing over time due
to efflux from the cell by pumps that remove citrate-iron complexes from ROS-stressed cells
(Frawley et al., 2013). Glucose-6-phosphate, a direct product of glucose, was not observed to
differ between tea and controlno tea, but PEP increased at 240 min, perhaps in response to the
reduction of alpha-ketoglutarate in the tea treatment between 40 and 240 min. Since alphaketoglutarate is a key intermediate in amino acid synthesis and degradation, the elevated levels
of alpha-ketoglutarate may also have been a response to high turnover in amino acids or simply
an overload of citrate and isocitrate from the tea that fluxed to alpha-ketoglutarate. While amino
acids other than valine, which is derived from pyruvate, showed no significant differences
between treatments, the production and consumption could have been higher in the tea treatment
and required additional alpha-ketoglutarate levels to be maintained.
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PEP and pyruvate are also major intermediates that regulate flux into the TCA cycle and
other cellular pathways. No significant differences in pyruvate were observed between
treatments, but PEP accumulated in the tea treatment at 240 min. This was unexpected since
increased pyruvate has been associated with recovery from environmental stressors (Morishige,
Fujimori, & Amano, 2013; J. Wu, Li, Cai, & Jin, 2014), but here the precursor to pyruvate, PEP,
and a product of pyruvate, acetylphosphate, were observed to significantly increase while
pyruvate had no significant difference (though there is a non-significant trend of increasing
pyruvate in tea vs. controlno tea) (Figure 11, Figure 12). When there is excess glucose, pyruvate
tends to flow to acetylphosphate and then to acetate that is excreted in “overflow metabolism”
(Wolfe 2005). When glucose is less abundant, acetate is taken back up and converted to
acetylphosphate and then to pyruvate or acetyl-coA. Acetylphosphate also acts as a global
signaling molecule for nitrogen assimilation and biosynthesis of flagella, pili, capsule, and
biofilm components (reviewed for E. coli in Wolfe, 2005). The accumulation of acetylphosphate
in tea at 240 min could mark the switch between glucose and glucose/acetate metabolism
delayed from the 40 min accumulation of acetylphosphate in controlno tea. Another possible
explanation is that acetylphosphate production was upregulated for its signaling functions,
particularly those involving membrane proteins since UDP-N-acetylglucosamine levels were
increased at the same time.
Overall, most of the changes in identifiable compounds revealed that S. Typhimurium
with the tea treatment was forced to handle an abundance of metabolic intermediates, which may
have prompted differential production of the major regulatory metabolites alpha-ketoglutarate
and acetylphosphate. An immediate metabolic response or influx from the tea may have been
responsible for elevated levels of metabolites, but neither can be verified without a flux analysis.
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At lower inoculum levels, the relatively higher concentrations of metabolic intermediates may
backlog the TCA cycle, glycolysis, and the PPP, since intermediates tend to act as feedback
inhibitors, resulting in minimal levels of NADH production, reduced respiration, and thus
reduced energy production. This cell state could leave S. Typhimurium more vulnerable to
abnormalities in membrane synthesis and any toxic effects of unusual tea metabolites like
yohimbine (Table 9) and the many unknown compounds that may have entered the cell (Table S
10). Yohimbine is known to have strong antibacterial activity against E. coli (MIC 4-32 µg/ml)
and had no cytotoxic effects on two different cell lines (Ozçelik et al., 2011). The compound
found in the current study is a match to yohimbine, but since yohimbine has not previously been
found in any processed or unprocessed Ilex paraguariensis samples, it may be a related
compound with the same chemical formula (C21H26N2O3). Vincamine (Pubchem compound
identifier (CID) 15376), rauwolscine (CID 643606), corynanthine (CID 92766), and
epivincamine (CID 637570) are all isomers of yohimbine; some are found in Rauwolfia ssp.
(Chatterjee et al., 1956) and Aspidosperma quebracho-blanco (Ewins, 1914) in South America.
Conclusion
Yerba mate extract contains potentially novel components that are capable of killing major
bacterial pathogens like S. Typhimurium, but only mechanistic information on previously known
pure components, not the comprehensive whole extract (including potentially novel compounds),
was available prior to this work. Now it is clear that yerba mate extract has a major impact on
central carbon metabolism, including the TCA cycle, PPP, and glycolysis pathways, by either
stimulating an immediate response or presenting the cells with large quantities of metabolic
intermediates that could block NADH production. Furthermore, catalase activity was reduced in
the presence of the tea at 240 min, but not directly inhibited, which suggests that catalase was
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downregulated due to effects of tea components or reduced ROS in the cell. Finally, this study
has found that membrane integrity was unaffected in the conditions tested, but UDP-Nacetylglucosamine, a cell wall precursor, and acetylphosphate, a global signaling compound that
can regulate membrane proteins were both upregulated at 240 min. This suggests that membrane
stress may be visible with a lower relative concentration of bacterial cells to tea compounds. This
first step toward characterizing the antibacterial activity of yerba mate extract has ruled out
several previously known mechanisms based on metabolomic trends and contributed information
on cell membrane integrity, catalase activity, altered S. Typhimurium metabolism, and putatively
identified yohimbine and a list of unidentifiable yerba mate components compounds capable of
entering or binding to S. Typhimurium cells. Future studies can now build on this knowledge to
generate more specific hypotheses of antibacterial mechanism for yerba mate extract and its
constituents and examine yohimbine and the set of currently unidentified compounds for their
individual and synergistic antibacterial mechanisms of action.
Materials and methods
Yerba mate aqueous extraction
A commercial brand of yerba mate tea (Taragui; 100% leaves, Argentina) was homogenized in a
blender to a particle size of <1 mm to be consistent with previous aqueous yerba mate studies
(Burris et al., 2012; Rempe et al., 2015). The homogenized tea was then extracted with ten times
its mass of water at 4 °C for 3.5 h, 0.22 μm polyethersulfone (PES) vacuum filtered (Corning
Life Sciences, Oneonta, NY, USA), frozen at -80 °C, and lyophilized using a FreeZone, 12 L
freeze dryer (Labconco, Kansas City, Mo. USA). Dried extracts were stored at room temperature
in a sealed plastic container prior to testing.
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Bacterial culture maintenance
S. Typhimurium DT104 strain 2576 was obtained from the Department of Food Science and
Technology at the University of Tennessee. Stock cultures of S. Typhimurium strains were
stored in 25% glycerol at -20 °C. Cultures were started from frozen stocks and re-inoculated
daily in tryptic soy broth (TSB) for 2-3 days before an experiment. To score the CFUs at a given
time interval, 100 μl samples were serially diluted in 0.1% sterile peptone and pour-plated in
duplicate using tryptic soy agar (TSA). S. Typhimurium plates were grown aerobically at 37 °C
for 24 h. Following incubation, CFUs were enumerated.
Bacterial growth experiments
Yerba mate extract (12.5 mg to 2 g) was reconstituted in MOPS buffer pH 7.3, adjusted to a final
pH of 7.3 with 1 M KOH, and syringe-filtered through 0.22 μm Express PES Membrane
(Millipore, Billerica, Mass., USA) prior to microbial susceptibility testing. All growth
experiments were performed in 125 ml flasks containing 12.5 ml TSB, 10 ml reconstituted yerba
mate extract or MOPS buffer pH 7.3, and 2.5 ml bacteria for a total volume of 25 ml. Overnight
bacterial cultures were diluted in 0.1 % sterile peptone to obtain 2.5 ml of ca. 5-6 log CFU/ml
starting concentrations or 5 ml of ca. 20 h culture was pelleted at 15,000 x g for 1 min at 4 °C,
the supernatant decanted, and the pellet resuspended in 5 ml PBS pH 7.4 to achieve a ca. 9 log
CFU/ml starting concentration. A no-bacteria control contained 2.5 ml PBS pH 7.4. Experiments
were conducted aerobically at 37 °C with shaking at 150 rpm. Initial growth experiments were
assessed at yerba mate extract concentrations of 0, 1.25, 2.5, 5, 10, 15, and 20 mg/ml yerba mate
extract with time points of 0, 4, 8, 12, and 24 h.
For mechanistic assays, experiments started with ca. 9 log CFU/ml cells to ensure
sufficient cells for assays. At this high cell density, no difference in mechanistic assays or growth
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was observed between yerba mate concentrations of 0 mg/ml, 10 mg/ml, 20 mg/ml, or 40 mg/ml,
so 80 mg/ml yerba mate extract was the treatment used for all mechanistic assays. Time points
ranged from 0-2 h for membrane integrity assays and 0-8 h for catalase activity assays. Up to 3
samples (1.5 ml for catalase activity, 700 μl for membrane integrity and biomass, and 100 μl for
CFU counts) were taken from each flask for mechanistic assays. Metabolomics extractions were
taken at times 0, 40 min (lag phase), and 4 h (exponential phase, significant difference in catalase
activity) in addition to samples for catalase activity, OD600, and CFU enumeration.
Crystal violet membrane integrity assay:
For membrane integrity and biomass, a 700 μl sample from a flask with or without bacteria
treated with yerba mate extract or MOPS buffer was taken, pelleted at 15,000 × g at 4 °C for 1
min, and washed at least three times with 500 μl PBS pH 7.4. The final pellet was resuspended in
700 μl PBS pH 7.4 and thoroughly vortexed. Two 200 μl samples were taken from each
resuspended pellet, put in a 96-well plate, and OD600 was read. The remaining 500 μl was again
pelleted at 15,000 × g at 4 °C for 1 min, the supernatant removed, and the pellet resuspended in
500 μl of 0.001% crystal violet freshly diluted in PBS pH 7.4 from a 1% aqueous solution. The
crystal violet tubes were vortexed and incubated for 10 min at 37 °C, pelleted at 15,000 × g, and
two 100 μl samples of the supernatant were added to a 96-well plate and read at crystal violet’s
absorbance wavelength of 590 nm. A blank sample of the crystal violet solution was used to
calculate percent of crystal violet uptake (((blank – sample)/blank) * 100)) (modified from Devi,
Nisha, Sakthivel, & Pandian, 2010).
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Catalase activity assay
A 1.5 ml sample from a flask with or without bacteria treated with yerba mate extract or MOPS
buffer was pelleted at 15,000 × g for 1 min at 4 °C and washed 3 times with 500 μl PBS pH 7.4.
The final pellet was resuspended in 300 μl PBS pH 7.4 and thoroughly vortexed. A simple foam
assay (Iwase et al., 2013) was conducted, in which 100 μl PBS pH 7.4, 100 μl washed sample in
PBS pH 7.4, 100 μl 1% Triton X-100 in PBS pH 7.4, and 100 μl of cold 30 % hydrogen peroxide
were added to a glass tube and mixed well. Technical duplicates were made for each sample. A
standard curve was made by reconstituting 0.0050 g catalase powder (Fisher, Nazareth, Penn.,
USA; 20000 U/g) in 1 ml PBS pH 7.4, then serially diluting to get 0, 2.5, 5, 7.5, and 10 catalase
activity units. Foam height (cm) was measured after foam had stabilized.
Metabolomics
Starting cultures had ca. 9 log CFU/ml cells or PBS pH 7.4 for media controls and 0 or 80 mg/ml
buffered yerba mate extract. At times 0, 40 min, and 4 h, 500 μl of cells were removed, diluted in
4.5 ml PBS pH 7.4, mixed, and vacuum filtered with 0.4 μm polycarbonate filters. The filters
were placed face-down in 1.3 ml cold (20 °C) extraction solvent (4:4:2 AcN:MeOH:H2O) for 20
min at 20 °C. In a 4 °C cold room, any remaining cells were washed from the filter with 400 μl
extraction solvent and pelleted at 16,200 × g for 5 min. All extraction solvent fractions for a
single sample were combined, dried under flowing nitrogen, resuspended in 300 μl of milliQ
water, and transferred to a centrifuge tube. Six biological replicates were done, but
contamination found in CFU plates prompted the exclusion of 3 replicates.
All samples were randomized in a 4 ˚C autosampler tray, from which 10 µl aliquots were
injected into a Synergi 2.5 micron Hydro-RP 100, 100 × 2.00 mm liquid chromatography column
(Phenomenex) maintained at 25 ˚C. A gradient across solvents A (97:3 water:methanol, 10 mM
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tributylamine, and 15 mM acetic acid ) and B (methanol) was run with 0% B for 5 min, 20 % B
for 8 min, 55% B for 2.5 min, 95% B for 3.5 min, and finally 0 % B for 6 min using a 200 µl/min
flow rate. The column eluted to an electrospray ionization (ESI) source coupled to a mass
spectrometer by a 0.1 mm internal diameter fused silica capillary tube. A Thermo Scientific
Exactive Plus orbitrap mass spectrometer was run in fullscan mode with negative ionization
using a published method (Lu et al., 2010). Instrument parameters were set to a spray voltage of
3 kV, a nitrogen sheath gas flow of 10 psi with a capillary temperature of 320 ˚C, an automatic
gain control (AGC) target of 3e6, a resolution of 140,000, a scan window of 85 to 800 m/z from
0 to 9 min and a scan window of 110 to 1000 m/z from 9 to 24 min.
Data analysis
Growth experiments were each set up and analyzed as a randomized block design, blocked on
replicate with sampling in duplicate. Treatment design was repeated measures with concentration
applied to each flask and time applied within each flask. Experiments were replicated three
times. Bacterial growth data were analyzed by analysis of variance (ANOVA) using mixed
models (SAS 9.4, SAS Institute, Cary, N.C., USA). Least significant differences (LSD) were
used to compare treatment mean values when significant differences (P<0.05) were found. Error
bars in all growth plots represent standard deviations of at least 3 replicates.
Metabolomics data analysis
Data was converted from Thermo .raw files to .mzML using msconvert from ProteoWizard
(Chambers, Maclean, & Burke, 2012). Peak selection was done with MAVEN (Melamud,
Vastag, & Rabinowitz, 2010) version 767 using the default model. Additional parameters are
listed in Table S 8. Peak intensity data in the resulting data matrix was normalized to biomass by
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scaling the intensity for each sample. All samples were arbitrarily scaled to the intensity value of
the first sample (7.35 × 108 CFU/ml counts). To investigate treatment and time differences, the
data matrix was analyzed as a randomized block design, blocked on replicate, with split plots of
time. A split plot analysis was considered sufficient when the change in Akaike information
criterion (AIC) was less than 3 between a repeated measures model with an adjusted correlation
structure (AR1) and a split plot model without a defined correlation structure. In 131 of the 7693
untargeted metabolites that were normal and had equal variance, the change in AIC was greater
than 3, so a repeated measures correlation structure was used in those cases. The three flask
treatments were controlno tea (0 mg/ml yerba mate extract with S. Typhimurium), tea (80 mg/ml
yerba mate extract with S. Typhimurium), and controlno bacteria (80 mg/ml yerba mate extract with
PBS pH 7.4 instead of bacteria). ANOVA assumptions were tested in R with the Levene test for
equal variance (P>0.05) and the Shapiro-Wilks test for normality (W>0.80). If these assumptions
were not met or if errors occurred in the lme analysis (i.e. “computationally singular matrix”),
metabolites were not included in the analysis. Otherwise, data were analyzed using linear mixed
models (package nlme, R Foundation for Statistical Computing, Vienna, Austria). P-values were
collected from a Tukey’s honestly significant difference (HSD) analysis implemented with the R
glht function from the multcomp package. Six contrast statements are displayed in the results
tables to focus on differences between controls (no tea or no bacteria) and the tea treatment.
Tukey HSD p-values were adjusted for multiple comparisons with the Benjamini-Hochberg
method (false discovery rate 0.05, R function p.adjust) as a single family across all metabolites.
ANOVA p-values across treatments were adjusted with the Benjamini-Hochberg correction as a
separate group across all metabolites. Metabolites with an ANOVA p-value of P< 0.05 across all
treatments that additionally had a Tukey HSD contrast p-value of P<0.05 were ranked by the
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most positive to most negative fold-change in the results tables. Both targeted (limited to
identifiable compounds) and untargeted analyses were performed, but only results from the
targeted analysis are displayed in Tables 9-14. Additional information for the targeted results is
in Table S 11 and all untargeted results are in Table S 10. Metabolites were identified based on
an in-house library of 257 compounds that had been run as pure standards on the same
instrument and with the same methods used for the samples. Names were matched to peaks
within 5 ppm m/z and 1.5 min of the observed m/z and retention time of the pure standard. If
multiple peaks were within the range of a single compound, the peak closest to the observed
retention time that did not appear to be a shoulder peak was selected for Tables 9-14 and Figures
11-13, S 5-S 7). All original multiply assigned peaks are in Table S 10 and Table S 11.
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Appendix
Figures

Figure 9. Growth of S. Typhimurium with A. ca. 6 log CFU/ml starting culture and 0 to 20
mg/ml yerba mate extract (n=3) or with B. ca. 9 log CFU/ml starting culture and 0 to 80 mg/ml
yerba mate extract (n=3 for 0.5 and 1 h and n=7 for all other time points). Error bars show
standard deviation. Statistically significant differences are marked by an asterisk for B only
(RBD repeated measures ANOVA).
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Figure 10. S. Typhimurium bioassays under controlno tea, tea, and controlno bacteria treatments to
test A. catalase activity with a simple foam assay and B. membrane integrity based on the uptake
of crystal violet dye. Error bars show standard deviation. Statistically significant differences
between controlno tea and tea in A or between controlno bacteria and tea in B are marked by an
asterisk (RBD repeated measures ANOVA). n=4 for both A and B.
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Figure 11. TCA cycle with plots displaying abundance of identifiable metabolites in three yerba
mate extract treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0, 40, 240 min).
Asterisks mark significant differences between one control treatment at a single time point and
the tea treatment at the corresponding time point. The citrate plot shows pooled results for
citrate/isocitrate and the succinate plot shows pooled results for succinate/methylmalonate since
these metabolite groups are indistinquishable with the methods used. Error bars represent 95%
confidence intervals. n=3
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Figure 12. Glycolysis pathways with plots displaying abundance of identifiable metabolites in
three yerba mate extract treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0,
40, 240 min). Asterisks mark significant differences between one control treatment at a single
time point and the tea treatment at the corresponding time point. Error bars represent 95%
confidence intervals. n=3
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Figure 13. Metabolites that are included in the discussion but not in the TCA cycle or glycolysis
pathways. Plots display abundance of identifiable metabolites in three yerba mate extract
treatments (controlno tea, tea, controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks
mark significant differences between one control treatment at a single time point and the tea
treatment at the corresponding time point. Error bars represent 95% confidence intervals. n=3
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Tables
Table 9. Significant differences between controlno_tea and tea at 0 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

353.1861
383.1158

12.25
5.49

Yohimbine
S-Adenosyl-L-homocysteine

>6223
107.31

6223
54606

Found in plant extracts
Cysteine and methionine metabolism

179.0559

6.22

myo-Inositol

7.13

1007861

Galactose, ascorbate, aldarate metab

179.0346

12.96

Hydroxyphenylpyruvate

6.83

78289

Phe, Tyr, Trp, and quinone biosynth

209.0305

12.17

D-Glucarate

6.43

918498

Ascorbate and aldarate metabolism

195.0511

5.13

D-Gluconate

5.93

463201

Ascorbate and aldarate metabolism

168.9812

12.53

Sulfolactate

5.68

358020

Cysteine and methionine metabolism

133.0143

11.66

Malate

5.59

17120480

TCA

191.02

12.76

Citrate/isocitrate

5.5

33537521

TCA; Ala, Asp, Glu metabolism

173.0089

13.14

Aconitate

5.31

2896247

TCA

115.0033

12.55

Fumarate

5.01

1551875

157.0366

1.3

Allantoin

4.75

146091

TCA, Arg, Tyr, Phe, pyruvate, nicotinate
metab.
Purine metabolism

175.0609

13.16

2-Isopropylmalate

4.63

272415

Pyruvate metab.; Val, Leu, Ile biosynth.

175.0244

6.47

Ascorbate

4.25

7640

Ascorbate and aldarate metab, PTS

213.0172

6.85

Deoxyribose phosphate

4.13

3983

PPP, pyrimidine metabolism

341.1095

1.34

Trehalose/Sucrose/Cellobiose

3.44

420093

Starch and sucrose metabolism

129.019

13.13

Citraconate

2.85

141501

Val, Leu, Ile biosynthesis

275.0177

12.41

6-Phospho-D-gluconate

2.43

393914

PPP

177.0401

6.86

Gluconolactone

2.37

27661

PPP

117.0191

10.91

Succinate/Methylmalonate

1.8

12531083

105.019

5.52

Glycerate

1.54

472651

TCA, Ala, Asp, Glu, Tyr, Phe, pyruvate
metab.
PPP, Gly,Ser,Thr, metabolism

157.0255

6.52

Dihydroorotate

1.43

3289

Pyrimidine biosynthesis

565.0484

12.38

UDP-glucose

1.37

309874

455.0977

14.43

FMN

1.24

4980

Starch, sucrose; ascorbate, aldarate;
pyrimidine metab.
Flavin biosynthesis, respiration

153.0193

12.55

2_3-Dihydroxybenzoate

1.07

20796

163.0399

15.03

Phenylpyruvate

-1.78

-9904

Aromatic amino acid, quinone,
enterobactin metabolism
Phe biosynthesis

175.0358

11.46

N-Carbamoyl-L-aspartate

-2.36

-89246

Pyrimidine biosynthesis

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide
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Table 10. Significant differences between controlno_tea and tea at 40 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

383.1158

5.49

S-Adenosyl-L-homocysteine

108.01

73846

Cysteine and methionine metabolism

353.1861

12.25

Yohimbine

60.41

5392

Found in plant extracts

179.0346

12.96

Hydroxyphenylpyruvate

52.08

57363

Phe, Tyr, Trp, and quinone biosynth

157.0366

1.3

Allantoin

7.63

154804

Purine metabolism

179.0559

6.22

myo-Inositol

7.35

1027983

Galactose, ascorbate, aldarate metab

209.0305

12.17

D-Glucarate

6.84

972917

Ascorbate and aldarate metabolism

168.9812

12.53

Sulfolactate

6.4

279361

Cysteine and methionine metabolism

133.0143

11.66

Malate

5.75

13629865

TCA

195.0511

5.13

D-Gluconate

5.75

439500

PPP

191.02

12.76

Citrate/isocitrate

5.47

26177730

TCA; Ala, Asp, Glu metabolism

175.0244

6.47

Ascorbate

5.01

8597

Ascorbate and aldarate metab, PTS

115.0033

12.55

Fumarate

4.97

1659376

TCA, Arg, Tyr, Phe, pyruvate metabolism

173.0089

13.14

Aconitate

4.75

2074842

TCA, glyoxylate metabolism

175.0609

13.16

2-Isopropylmalate

3.45

103004

Val, Leu, Ile, pyruvate metabolism

341.1095

1.34

Trehalose/Sucrose/Cellobiose

3.2

333984

Starch and sucrose metabolism

117.0191

10.91

Succinate/Methylmalonate

2.49

13280583

129.019

13.13

Citraconate

2.19

95207

TCA,Ala,Asp,Glu,Tyr,Phe,pyruvate
metab,
Val, Leu, Ile biosynthesis

177.0401

6.86

Gluconolactone

2.18

23413

PPP

145.0143

12.16

alpha-Ketoglutarate

2.13

3145953

TCA, amino acid and quinone biosynth

455.0977

14.43

FMN

1.79

7469

Flavin biosynthesis, respiration

105.019

5.52

Glycerate

1.61

411390

PPP, Gly,Ser,Thr, metabolism

116.0714

1.11

Valine

1.6

407

288.1204

7.56

Ophthalmate

0.86

110577

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Cysteine and methionine metabolism

606.075

12.42

UDP-N-acetylglucosamine

0.68

105219

115.0398

12.39

2-Oxoisovalerate

-0.62

-100110

168.9906

9.32

Dihydroxyacetone phosphate

-0.68

-124034

Lipopolysaccharide, peptidoglycan
biosynth; amino and nucleotide sugar
metab.
Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Glycolysis, gluconeogenesis

131.0825

1.23

Ornithine

-1.29

-3130

Arg biosynth; Arg and Pro metabolism

368.9995

12.75

Sedoheptoluse bisphosphate

-1.36

-20176

PPP

319.0438

7.17

Octulose 8/1P

-1.37

-6145

Methylthiolincosamide biosynthesis

258.0388

1.49

Glucosamine phosphate

-1.67

-12173

157.0255

6.52

Dihydroorotate

-1.88

-7081

Ala, Asp, Glu metab; PTS; amino and
nucleotide sugar metab
Pyrimidine biosynthesis

163.0399

15.03

Phenylpyruvate

-1.94

-32315

Phe biosynthesis

138.98

11.8

Acetylphosphate

-2.21

-8842

Taurine, pyruvate, carbon metab

175.0358

11.46

N-Carbamoyl-L-aspartate

-5.52

-1720323

Pyrimidine biosynthesis

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
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Table 10 notes continued
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide

135

Table 11. Significant differences between controlno_tea and tea at 240 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

179.0559

6.22

myo-Inositol

8.13

1745217

Galactose, ascorbate, aldarate metab

289.0333

7.24

Sedoheptulose 1/7-phosphate

6.26

654240

PPP, lipopolysaccaride biosynthesis

322.0449

9.04

CMP

5.77

267595

Pyrimidine metabolism

175.0244

6.47

Ascorbate

5.38

7728

Ascorbate and aldarate metab, PTS

115.0033

12.55

Fumarate

5.37

1092892

133.0143

11.66

Malate

4.28

6963500

TCA, Arg, Tyr, Phe, pyruvate, nicotinate
metab.
TCA

138.98

11.8

Acetylphosphate

4.04

11563

Taurine, pyruvate, carbon metab

175.0609

13.16

2-Isopropylmalate

3.7

24484

Val, Leu, Ile, pyruvate metabolism

117.0191

10.91

Succinate/Methylmalonate

3.38

13699174

166.9751

13.06

Phosphoenolpyruvate

3.36

241253

177.0401

6.86

Gluconolactone

3.04

13053

TCA,Ala,Asp,Glu,Tyr,Phe,pyruvate
metab,
TCA, glycolysis, gluconeogenesis, PTS,
Phe, Tyr, Tryp biosynth
PPP

153.0193

12.55

2_3-Dihydroxybenzoate

2.98

28200

275.0177

12.41

6-Phospho-D-gluconate

2.31

4789

Aromatic amino acid, quinone,
enterobactin metabolism
PPP

129.019

13.13

Citraconate

1.75

22694

Val, Leu, Ile biosynthesis

258.0388

1.49

Glucosamine phosphate

1.56

11003

115.0398

12.39

2-Oxoisovalerate

1.45

112597

145.0143

12.16

alpha-Ketoglutarate

1.35

391899

Ala, Asp, Glu metab; PTS; amino and
nucleotide sugar metab
Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
TCA, amino acid and quinone biosynth

+

662.1028

8.8

NAD

0.7

103153

Respiration, thiamine metabolism

173.0929

1.49

N-Acetylornithine

-2.08

-61697

Arginine biosynthesis

116.0714

1.11

Valine

-3.73

-1787

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide
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Table 12. Significant differences between controlno_bacteria and tea at 0 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

115.0398

12.39

2-Oxoisovalerate

-0.64

-55405

146.0459

4.72

Glutamate

-1.73

-6966631

191.02

12.76

Citrate/isocitrate

-1.8

-2.4E+07

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Arg, Ala, Asp, Glu, Pro, His, Taurine,
glutathione metabolism
TCA; Ala, Asp, Glu metabolism

175.0609

13.16

2-Isopropylmalate

-2.06

-215728

Pyruvate metab.; Val, Leu, Ile biosynth.

129.019

13.13

Citraconate

-2.28

-130526

Val, Leu, Ile biosynthesis

173.0929

1.49

N-Acetylornithine

-2.69

-18970

Arginine biosynthesis

166.9751

13.06

Phosphoenolpyruvate

-2.74

-13749

288.1204

7.56

Ophthalmate

-2.91

-252922

TCA, glycolysis, gluconeogenesis, PTS,
Phe, Tyr, Tryp biosynth
Cysteine and methionine metabolism

175.0358

11.46

N-Carbamoyl-L-aspartate

-2.97

-18771

Pyrimidine biosynthesis

115.0033

12.55

Fumarate

-3

-1401927

565.0484

12.38

UDP-glucose

-3.78

-469416

173.0089

13.14

Aconitate

-4

-2785595

TCA, Arg, Tyr, Phe, pyruvate, nicotinate
metab.
Starch, sucrose; ascorbate, aldarate;
pyrimidine metab.
TCA

662.1028

8.8

NAD+

-4

-99637

Respiration, thiamine metabolism

455.0977

14.43

FMN

-4.71

-8292

Flavin biosynthesis, respiration

116.0714

1.11

Valine

-5.68

-9527

145.0143

12.16

alpha-Ketoglutarate

-5.69

-418654

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
TCA, amino acid and quinone biosynth

275.0177

12.41

6-Phospho-D-gluconate

-5.82

-474798

PPP

368.9995

12.75

Sedoheptoluse bisphosphate

-5.92

-10829

PPP

229.0119

7.15

Ribose phosphate

-6.13

-17148

PPP, purine metabolism

168.9906

9.32

Dihydroxyacetone phosphate

-9.46

-176509

Glycolysis, gluconeogenesis

784.152

15.1

FAD

-50.77

-3943

Riboflavin metabolism, respiration

138.98

11.8

Acetylphosphate

-103.07

-2147

Taurine, pyruvate, carbon metab

131.0825

1.23

Ornithine

-103.09

-546

Arg biosynth; Arg and Pro metabolism

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide
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Table 13. Significant differences between controlno_bacteria and tea at 40 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

115.0398

12.39

2-Oxoisovalerate

-0.95

-89485

116.0714

1.11

Valine

-1.43

-383

191.02

12.76

Citrate/isocitrate

-1.6

-1.8E+07

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
TCA; Ala, Asp, Glu metabolism

129.019

13.13

Citraconate

-1.69

-84205

Val, Leu, Ile biosynthesis

146.0459

4.72

Glutamate

-2.39

-7653190

455.0977

14.43

FMN

-3.57

-9620

Arg, Ala, Asp, Glu, Pro, His, Taurine,
glutathione metabolism
Flavin biosynthesis, respiration

173.0089

13.14

Aconitate

-3.66

-1985077

TCA

163.0399

15.03

Phenylpyruvate

-3.7

-10513

Phe biosynthesis

322.0449

9.04

CMP

-3.9

-7209

Pyrimidine metabolism

115.0033

12.55

Fumarate

-3.98

-1605564

166.9751

13.06

Phosphoenolpyruvate

-4.38

-19162

368.9995

12.75

Sedoheptoluse bisphosphate

-4.47

-12248

TCA, Arg, Tyr, Phe, pyruvate, nicotinate
metab.
TCA, glycolysis, gluconeogenesis, PTS,
Phe, Tyr, Tryp biosynth
PPP

784.152

15.1

FAD

-4.6

-6412

Riboflavin metabolism, respiration

259.0227

6.66

Glucose 6-phosphate

-4.8

-205988

289.0333

7.24

Sedoheptulose 1/7-phosphate

-4.88

-22783

PPP, lipopolysaccaride biosynthesis

175.0358

11.46

N-Carbamoyl-L-aspartate

-5.11

-37308

Pyrimidine biosynthesis

229.0119

7.15

Ribose phosphate

-5.83

-16429

PPP, purine metabolism

565.0484

12.38

UDP-glucose

-6.59

-797530

138.98

11.8

Acetylphosphate

-6.73

-2407

Starch, sucrose; ascorbate, aldarate;
pyrimidine metab.
Taurine, pyruvate, carbon metab

606.075

12.42

UDP-N-acetylglucosamine

-6.81

-275975

275.0177

12.41

6-Phospho-D-gluconate

-6.86

-437177

Lipopolysaccharide, peptidoglycan
biosynth; amino and nucleotide sugar
metab.
PPP

288.1204

7.56

Ophthalmate

-7.58

-244381

Cysteine and methionine metabolism

145.0143

12.16

alpha-Ketoglutarate

-9.45

-4073374

TCA, amino acid and quinone biosynth

168.9906

9.32

Dihydroxyacetone phosphate

-10.51

-206741

Glycolysis, gluconeogenesis

321.0495

10.62

dTMP

-50.38

-914

Pyrimidine metabolism

131.0825

1.23

Ornithine

<-2177

-2177

Arg biosynth; Arg and Pro metabolism

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide
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Table 14. Significant differences between controlno bacteria and tea at 240 min
mz

rt

Putative name

Fold change

Mean diff.

Pathways/Notes

213.0172

6.85

Deoxyribose phosphate

3.12

6161

PPP, pyrimidine metabolism

191.02

12.76

Citrate/isocitrate

3.07

16187946

TCA; Ala, Asp, Glu metabolism

177.0401

6.86

Gluconolactone

2.29

57692

PPP

116.0714

1.11

Valine

2.26

553

179.0346

12.96

Hydroxyphenylpyruvate

1.53

29855

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Phe, Tyr, Trp, and quinone biosynth

105.019

5.52

Glycerate

1.51

486848

PPP, Gly,Ser,Thr, metabolism

341.1095

1.34

Trehalose/Sucrose/Cellobiose

1.45

242645

Starch and sucrose metabolism

115.0398

12.39

2-Oxoisovalerate

-0.65

-64809

179.0559

6.22

myo-Inositol

-1.22

-1001285

Val, Leu, Isoleu biosynth; pantothenate
and coA biosynth
Galactose, ascorbate, aldarate metab

321.0495

10.62

dTMP

-1.53

-1093

Pyrimidine metabolism

157.0255

6.52

Dihydroorotate

-1.99

-3939

Pyrimidine biosynthesis

173.0929

1.49

N-Acetylornithine

-2.64

-16085

Arginine biosynthesis

455.0977

14.43

FMN

-3.36

-8022

Flavin biosynthesis, respiration

163.0399

15.03

Phenylpyruvate

-3.77

-29757

Phe biosynthesis

662.1028

8.8

NAD+

-4.33

-254901

Respiration, thiamine metabolism

168.9906

9.32

Dihydroxyacetone phosphate

-4.7

-18053

Glycolysis, gluconeogenesis

145.0143

12.16

alpha-Ketoglutarate

-5.51

-629579

TCA, amino acid and quinone biosynth

322.0449

9.04

CMP

-6.03

-268434

Pyrimidine metabolism

289.0333

7.24

Sedoheptulose 1/7-phosphate

-6.49

-655535

PPP, lipopolysaccaride biosynthesis

166.9751

13.06

Phosphoenolpyruvate

-6.83

-265009

258.0388

1.49

Glucosamine phosphate

-8.21

-16604

175.0358

11.46

N-Carbamoyl-L-aspartate

-8.28

-879679

TCA, glycolysis, gluconeogenesis, PTS,
Phe, Tyr, Tryp biosynth
Ala, Asp, Glu metab; PTS; amino and
nucleotide sugar metab
Pyrimidine biosynthesis

138.98

11.8

Acetylphosphate

-105.41

-12313

Taurine, pyruvate, carbon metab

131.0825

1.23

Ornithine

-106.24

-1211

Arg biosynth; Arg and Pro metabolism

mz = mass to charge ratio
rt = retention time
”tea” refers to S. Typhimurium treated with 80 mg/ml aqueous yerba mate extract
”controlno_tea“ refers to S. Typhimurium treated with buffer instead of tea
”controlno_bacteria” refers to tea with PBS pH 7.4 instead of bacteria
Fold change is expressed as log2(control/tea)
Mean difference is the difference between the adjusted intensity means of control – tea
PPP = pentose phosphate pathway; TCA = tricarboxylic acid cycle; PTS = phosphoenolpyruvate transferase system
UDP = uridine diphosphate; FMN = Flavin mononucleotide; CMP = cytidine monophosphate; NAD = nicotinamide adenine
dinucleotide
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Supporting information
Supporting figures

Figure S 4. Optical density at 600 nm of S. Typhimurium under 3 treatment types (controlno tea,
tea, controlno bacteria). There were no significant differences between controlno tea and tea
treatments. Error bars represent standard deviation. n=4
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Figure S 5. Pentose phosphate pathway with plots displaying abundance of identifiable
metabolites in three yerba mate extract treatments (controlno tea, tea, controlno bacteria) and at three
timepoints (0, 40, 240 min). Asterisks mark significant differences between one control
treatment at a single time point and the tea treatment at the corresponding time point. Error bars
represent 95% confidence intervals. n=3
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Figure S 6. Valine, leucine, and isoleucine biosynthesis pathway with plots displaying
abundance of identifiable metabolites in three yerba mate extract treatments (controlno tea, tea,
controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks mark significant differences
between one control treatment at a single time point and the tea treatment at the corresponding
time point. Error bars represent 95% confidence intervals. n=3
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Figure S 7. Additional metabolites with significant differences between treatments; plots
display abundance of identifiable metabolites in three yerba mate extract treatments (controlno tea,
tea, controlno bacteria) and at three timepoints (0, 40, 240 min). Asterisks mark significant
differences between one control treatment at a single time point and the tea treatment at the
corresponding time point. Error bars represent 95% confidence intervals. n=3
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Supporting tables

Table S 8. Peak-picking parameters for metabolomics data analysis with Maven software. These
parameters were used for both targeted and untargeted analyses but targeted analyses were
limited to identifiable compounds.
Parameter
Mass domain resolution
Time domain resolution
EIC smoothing
Peak grouping (maximum group retention time difference)
Drop top x% intensities to get baseline
Baseline smoothing
Peak classifier model
Minimum good peaks/group
Minimum signal/baseline ratio
Minimum peak width
Minimum signal/blank ratio
Minimum peak intensity

Value
5 ppm
10 scans
3 scans
0.50 min
80%
10 scans
default.model
3
5
10 scans
5
10000 ions
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Table S 9. Pure catalase tested for activity in the presence of yerba mate extract (controlno
bacteria ). Pure catalase (5 U) in buffer was compared to pure catalase (5 U) with incubated
yerba mate extract (controlno bacteria). No significant difference was observed between
catalase in buffer and catalase treated with incubated yerba mate extract sampled at
different times.

B. Average catalase activity with controlno
A. Average standard catalase curve
Activity
Foam
units
height
0
0±0
2.5
0.73 ± 0.04
5
1.53 ± 0.04

7.5
2.35 ± 0.07
10
3.1 ± 0.14

bacteria

Time
(minutes)
0
40
100
120
240
480

Foam
height
1.54 ± 0.18
1.58 ± 0.11
1.58 ± 0.09
1.58 ± 0.09
1.53 ± 0.08
1.54 ± 0.05

Foam height (cm) ± standard deviation
n=4 for average catalase activity with controlno bacteria
n=2 for standard curves since experiments were run in parallel in sets of 2
5 activity units of pure catalase (boxed in standard curve table) were tested for catalase activity
after the addition of 50 µl of controlno bacteria treatment from 0 to 8 hours
There was no significant difference (P=0.97) in foam height between pure catalase treated with
the controlno bacteria treatment (5 activity units) and pure catalase under standard testing conditions
(5 activity units) with the non-parametric Kruskal-Wallis test (R function ‘kruskal.test’ used with
the ‘interaction’ function to expand model to a one-way design) that was used to account for
unequal variance from unbalanced data.
Table S 10. Complete list of all metabolites found with LC-MS. (attachment)
Table S 11. List of all identified metabolites found with LC-MS. (attachment)
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CHAPTER VI
CONCLUSION
The increasing prevalence of multi-drug resistant bacterial pathogens threatens to return us to a
pre-antibacterial era if we fail to find new antibacterial compounds or alternative treatments.
Nevertheless, we are lucky to have an immense, diverse pool of phytochemicals to draw from in
our search for antibacterials. Many plant extracts are already known to have some degree of
antibacterial activity, but information on the constituents contributing to antibacterial activity and
their mechanisms of action are needed to push the field forward. This dissertation makes a small
step in this direction by seeking the major chemical components with antibacterial activity and
assaying yerba mate extract for a series of potential antibacterial mechanisms of action. A
preliminary review of the literature for antibacterial mechanisms of action of phenolic
compounds discussed a role for systems biology as a means of screening for novel mechanisms
of action. Then, using a unique search method, GC-MS metabolite data from forty-two fractions
of yerba mate extract were each characterized for antibacterial activity against MRSA and S.
aureus and compounds were ranked by their contribution to the discrimination of antibacterial
from non-antibacterial activities. Based on this assessment, 5-hydroxy-pipecolic acid and quinic
acid were found to be candidates for involvement in antibacterial activity against MRSA,
although pure 3, 4-dihydroxybenzaldehyde showed the best antibacterial activity of the pure
compounds assayed. Moving to a different system, this work next surveyed the accumulated
metabolic products of L. casei and S. Typhimurium when grown with yerba mate extract in a
milk system. While few notable changes were observed in the significantly accumulated
metabolic products of either L. casei or S. Typhimurium, the presence of increased oxalomalate
in S. Typhimurium suggested inhibition of aconitase. The hypothesis of phenolic chelation as a
possible mechanism of action based on knowledge of phenolic chelation tendencies revealed that
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the presence of exogenous iron sulfate prompted the partial recovery of S. Typhimurium. Next,
after shifting from S. Typhimurium in a milk system to a common growth media for further
mechanistic assessments, bioassays revealed that cell membrane integrity was not definitively
changed but catalase activity was reduced in the presence of yerba mate extract. Furthermore,
altered abundances of metabolites were observed in central carbon metabolism, a cell wall
precursor, two metabolic regulators, an energy molecule, and a hit to the known antibacterial
compound yohimbine. We anticipate that the continuing work in the areas of antibacterial
discovery and mechanisms will lead to a better understanding of how antibacterial compounds
function and how resistance mechanisms can be dealt with.
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